Home
  >  
Section 33

EurekaMag Full Text Articles Chapter 32,474



References:

Katz, David H.; Habbema, L.; De Boulle, K.; Roders, G.A. 1994: N-Docosanol cream is an effective topical treatment of recurrent herpes labialis. Antiviral Research 23(Suppl 1): 75
Marcelletti, J.F.; Lusso, P.; Katz, D.H. 1996: N-Docosanol inhibits in vitro replication of HIV and other retroviruses. Aids Research and Human Retroviruses 12(1): 71-74
Thomas, T.H.; Rutherford, P.A.; Wilkinson, R. 1993: N-Ethyl maleimide inhibition of human erythrocyte sodium, lithium countertransport Relation to abnormal activity. Journal of Physiology (Cambridge) 459: 383P
Angelico, M.; Mangiameli, A.; Della Guardia, P.; Sofia, M.; Nistri, A.; Maina, M.; Baiocchi, L.; Blasi, A. 1993: N-Ethyltauroursodeoxycholic acid, an amidated bile salt analogue resistant to deconjugation Metabolism and bile secretory properties after duodenal infusion in the rat. Hepatology 18(4 Part 2): 178A
Fisher, C.H. 1995: N-Fatty acids Comparison of published densities and molar volumes. Journal of the American Oil Chemists' Society 72(6): 681-685
Yamaoka, K.; Yusuf, I.; Seyama, I. 1992: N-Feruloyltyramine blocks the cardiac inward rectifier potassium channel. Japanese Journal of Physiology 42(Suppl ): S268
Kimoto, M.; Tsuji, H.; Ogawa, T. 1993: N-G,N-G-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating tissue and cell systems of rats. Amino Acids 5(3): 431-432
Yokomori, H.; Oda, M.; Kamegaya, Y.; Kazemoto, S.; Ogi, M.; Tsukada, N.; Akiba, Y.; Nakamura, M.; Muraoka, M.; Ishii, H. 1995: N-G-L monomethyl arginine enhances bile canalicular contractions in primary culture- involvement of intracytoplasmic free calcium ion and Ca++-ATPase activity. Gastroenterology 108(4 Suppl): A1204
Olken, N.M.; Marletta, M.A. 1993: N-G-Methyl-L-arginine is an alternate substrate and mechanism-based inhibitor of nitric oxide synthase. FASEB Journal 7(7): A1203
Paik, W.K.; Kim, S. 1993: N(G)-Methylarginines: Biosynthesis, biochemical function and metabolism. Amino Acids 4(3): 267-286
Watson, M.; Poth, M.; Francis, G. 1993: N-G-Monomethyl-L-arginine directly stimulates in vitro Leydig cell testosterone production. Pediatric Research 33(5 Suppl): S19
Watkins, R.; Cook, I.; Mcleod, R. 1993: N-G-Monomethyl-L-arginine does not inhibit depressor responses to acetylcholine in rats. FASEB Journal 7(3-4): A775
Piotrovskij, V.K.; Kállay, Z.; Horecký, J.; Trnovec, T.; Raberger, G.; Krejcy, K. 1994: NG-nitro-L-arginine is not involved in enterohepatic cycling in rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals 22(2): 338-339
Weintraub, N.L.; Sprague, R.S.; Stephenson, A.H.; Joshi, S.N.; Branch, C.A.; Lonigro, A.J. 1993: N-G-Nitro-L-arginine reduces venous admixture in intact anesthetized dogs. FASEB Journal 7(3-4): A650
Mayers, I.; Johnson, D.; Hurst, T. 1995: N-G-methyl-L-arginine restores hypoxic pulmonary vasoconstriction following burns in anaesthetized rabbits. Clinical and Investigative Medicine 18(4 Suppl): B24
Nowicki, P. 1994: N-G-monomethyl-L-arginine alters the relationship between pressure and flow in gut from 3-, but not 35-day old swine. Pediatric Research 35(4 Part 2): 244A
Rutten, M.J.; Muller, P.J.; Jou, A.J.; Fowler, W.M.; Bartos, D.; Meshul, C.; Allen, C.; Sheppard, B.C.; Crass, R.A.; Deveney, C.W.; Trunkey, D.D. 1996: N-G-monomethyl-L-arginine modulates H pylori induced cytoskeletal changes in gastric mucous epithelial cells. Gastroenterology 110(4 Suppl): A246
Puscas, I. 1995: N-G-monomethyl-L-arginine powerfully activates carbonic anhydrase I , while sodium nitroprusside as a source of nitric oxide, completely inhibits enzyme activity. Gastroenterology 108(4 Suppl): A672
Stefanovic Racic, M.; Meyers, K.; Meschter, C.; Coffey, J.W.; Hoffman, R.A.; Evans, C.H. 1994: N-G-monomethyl-L-arginine suppresses the development of adjuvant arthritis in rats. Moncada, S, Feelisch, M, Busse, R, Higgs, E A Portland Press Proceedings; The biology of nitric oxide, Vol 4 Enzymology, biochemistry and immunology 417-420
Kilbourn, R.; Fonseca, G.; Ewer, M.; Price, K.; Jones, E.; Logothetis, C.; Griffith, O. 1994: N-G-monomethyl-L-arginine, an inhibitor of nitric oxide production, reverses interleukin-2-mediated hypotension in humans. Moncada, S, Feelisch, M, Busse, B, Higgs, E A Portland Press Proceedings; The biology of nitric oxide, Vol 3 Physiological and clinical aspects 454-458
Chaturvedi, R.; Hjortdal, V.; Stenbg, E.; Ravn, H.; White, P.; Pedersen, J.; Christensen, T.; Thompsen, A.B.; Sorensen, K.; Redington, A. 1997: N-G-monomethyl-l-arginine improves left ventricular systolic function late after cardiopulmonary bypass in neonatal pigs. Journal of the American College of Cardiology 29(2 Suppl A): 99A
Charriaut Marlangue, C.; Margaill, I.; Walsh, R.J.; Plotkine, M.; Ben Ari, Y. 1995: N-G-nitro L-arginine methylester reduces cortical infarct and necrotic damage but not apoptotic cell loss. Society for Neuroscience Abstracts 21(1-3): 998
Glaser, E.; Lacolley, P.; Challande, P.; Brisac, A.B.; Safar, M.; Laurent, S. 1993: N-G-nitro-L-arginine and carotid arterial pressure-diameter relationship in vivo in rats. Journal of Hypertension 11(Suppl 5): S427-S428
Yamanaka, A.; Ishikawa, T.; Goto, K. 1997: N-G-nitro-L-arginine and indomethacin resistant relaxation induced by acetylcholine in the guinea pig coronary artery. Japanese Journal of Pharmacology 73(Suppl 1): 199P
Valdovinos, M.A.; Meulemans, A.L.; De Ridder, W.J.E.; Van Bergen, P.J.E.; Schuurkes, J.A.J. 1993: N-G-nitro-L-arginine inhibits NANC relaxations and unmasks cholinergic contractions in the isolated lower esophageal sphincter of the pig. Gastroenterology 104(4 Suppl): A861
Kurantsin Mills, J.; Cassidy, M.M.; Stafford, R.E.; Wagner, T.; Weglicki, W.B. 1995: N-G-nitro-L-arginine methyl ester augments circulating inflammatory cells during magnesium-deficiency in the rat. FASEB Journal 9(4): A709
Lo, S.; Lot, T.Y.; Hind, R.; Wilson, V.G. 1995: N-G-nitro-L-arginine methyl ester can elicit endothelium-independent contractions in the porcine isolated coronary artery. British Journal of Pharmacology 116(Proceedings Suppl ): 188P
Rivas-Cabañero, L.; Valdivielso, J.M.; López-Novoa, J.M. 1996: NG-nitro-L-arginine methyl ester causes glomerular nitrite production in long-term incubations. Nephron 73(1): 97-98
Goldsmith, P.C.; Levell, N.J.; Foreman, J.C.; Dowd, P.M. 1994: N-G-nitro-L-arginine methyl ester is an inhibitor of cutaneous vasodilatation due to calcitonin gene-related peptide. Journal of Investigative Dermatology 102(4): 645
Hellyer, P.W.; Plummer, D.D.; Johnson, L.W.; Olson, N.C. 1995: N-G-nitro-L-arginine methyl ester potentiates endotoxin-induced cardiopulmonary dysfunction and release of eicosanoids in pigs. FASEB Journal 9(3): A131
Lamarca, S.; Carr, G.; Dunn, R.W. 1995: N-G-nitro-L-arginine methyl ester, N-G-nitro-L-arginine and 7-nitroindazole are anxiolytic in the Vogel lick-shock conflict paradigm following bolus intravenous administration. FASEB Journal 9(4): A922
Medhrust, A.D.; Parson, A.A.; Kay, S.L.; Murkitt, K.L.; Smith, S.J.; Hunter, A.J. 1994: N-G-nitro-L-arginine p-nitroanilide inhibits neurogenic and endothelium-dependent relaxation in peripheral tissues. Moncada, S, Feelisch, M, Busse, B, Higgs, E A Portland Press Proceedings; The biology of nitric oxide, Vol 3 Physiological and clinical aspects 430-434
Piotrovskij, V.K.; Kállay, Z.; Krejcy, K.; Horecký, J.; Trnovec, T.; Raberger, G. 1993: NG-nitro-L-arginine pharmacokinetics in rats after a single intravascular and oral dose: an appearance of secondary concentration time peaks. Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(5): 962-964
Yamamoto, R.; Niina, H.; Asada, Y.; Sumiyoshi, A.; Takasaki, K.; Wada, A. 1993: N-G-nitro-L-arginine suppresses noradrenaline overflow in rat isolated perfused mesenteric vasculature. Japanese Journal of Pharmacology 61(Suppl 1): 117P
Huskey, S.E.; Magdalou, J.; Ouzzine, M.; Siest, G.; Chiu, S.H. 1994: N-glucuronidation reactions. III. Regioselectivity of N-glucuronidation of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole using human and rat recombinant UDP-glucuronosyltransferases stably expressed in V79 cells. Drug Metabolism and Disposition: the Biological Fate of Chemicals 22(4): 659-662
Eichele, A.; Boldt, W.; Knau, B.; Nicke, A.; Mutschler, E.; Markwardt, F.; Schmalzing, G. 1998: N-Glycan scanning and epitope insertion confirms predicted membrane topology of P2X3 receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 357(4): R32
Kimura, S.; Toyoshima, K.; Cheng, J.; Oda, K.; Saku, T. 1998: N-Glycosylation of perlecan core protein in salivary adenoid cystic carcinoma cells. Molecular Biology of the Cell 9(Suppl ): 57A
Korsmeyer, K.K.; Guan, S.; Yang, Z.C.; Falick, A.M.; Ziegler, D.M.; Cashman, J.R. 1998: N-Glycosylation of pig flavin-containing monooxygenase form 1: determination of the site of protein modification by mass spectrometry. Chemical Research in Toxicology 11(10): 1145-1153
Rice, P.J. 1995: N-Heptanol reverses postsynaptic denervation supersensitivity in the rat vas deferens. FASEB Journal 9(3): A109
Nair, H.K. 1997: N-Het-substituted glycerophosphoethanolamines. Official Gazette of the United States Patent and Trademark Office Patents 1205(5): 3900
Norcini, G.; Santangelo, F. 1995: N-Heteroaryl substituted derivatives of propanamide useful in the treatment of cardiovascular diseases. Official Gazette of the United States Patent and Trademark Office Patents 1177(1): 337
Nagamine, M.; Yamamoto, K.; Matsui, Y.; Horiuchi, K.; Yoshida, M. 1995: N-Heteroaryl--phenylurea derivatives, their production and use. Official Gazette of the United States Patent and Trademark Office Patents 1180(1): 362
Takeuchi, Y. 1993: N-hexane polyneuropathy in Japan: a review of n-hexane poisoning and its preventive measures. Environmental Research 62(1): 76-80
Collis, C.S.; Rice Evans, C.; Davies, M.J. 1993: N-Hexano-N-methyl-hydroxamate, a novel drug, attenuates reperfusion-induced contracture in the isolated perfused rat heart. Journal of Physiology (Cambridge) 459: 359P
Gouverneur, V.; Lalloz, M.N. 1996: N-Hydroxy-alpha-amino phosphonate derivatives as potential haptens for eliciting catalytic antibodies. Tetrahedron Letters 37(35): 6331-6334
Mano, T.; Stevens, R.W.; Nakane, M. 1995: N-Hydroxyurea derivatives as antiallergy and antiinflammatory agents. Official Gazette of the United States Patent and Trademark Office Patents 1180(1): 358
Costales, M.J.; Ehr, R.J.; Kleschick, W.A.; Van, H., J.C.; Reifschneider, W. 1995: N-Indazolyl1,2,4triazolo1,5-Cpyrimidine-2-sulfonamide herbicides. Official Gazette of the United States Patent and Trademark Office Patents 1178(1): 331-332
Ma, Z.Q.; Santagati, S.; Pollio, G.; Cattaneo, E.; Maggi, A. 1993: N-MYC and c-fos mRNA levels in estrogen activated neuroblastoma cells. Society for Neuroscience Abstracts 19(1-3): 881
Sivak, L.F.; Dillon, P.A.; Johnston, J.M.; Brodeur, G.M.; Carroll, W.L. 1993: N-MYC promoter activity in human neuroblastoma. Pediatric Research 33(4 Part 2): 148A
Barb, C.R.; Barrett, J.B.; Rampacek, G.B.; Kraeling, R.R. 1992: N-Methyl-D,L-aspartate modulates luteinizing hormone but not growth hormone secretion from pig pituitary cells. Society for Neuroscience Abstracts 18(1-2): 444
Hallak, M.; Hotra, J.W. 1997: N-Methyl-D-Aspartate receptor binding in the rat brain Effect of pregnancy stage. American Journal of Obstetrics and Gynecology 176(1 Part 2): S101
Evans, P.D.; Reale, V.; Merzon, R.M.; Villegas, J. 1992: N-Methyl-D-aspartate and non-NMDA type glutamate receptors modulate the membrane potential of the Schwann cell of the squid giant nerve fibre. Journal of Experimental Biology 173: 229-249
Verma, A.; Kulkarni, S.K. 1995: N-Methyl-D-aspartate receptor participation in Parkinson's disease, a neurodegenerative disorder. Annals of the new York Academy of Sciences 765: 327
D.L.renzo, R.J.; Sombati, S. 1996: N-Methyl-D-aspartate receptor-dependent induction of epileptogenesis in an in vitro hippocampal model of epilepsy. Neurology 46(2 Suppl): A357
Marini, A.M.; Damschroder Williams, P.; Paul, S.M. 1993: N-Methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Amino Acids 5(3): 445
Bockaert, J.; Olivier, M.; Manzoni, O.; Lafon Cazal, M.; Marin, P.; Fagni, L. 1993: N-Methyl-D-aspartate receptors and nitric oxide. Journal of Neurochemistry 61(Suppl ): S52
Cumberbatch, M.J.; Headley, P.M. 1993: N-Methyl-D-aspartate receptors and spinal nociceptive processing. Society for Neuroscience Abstracts 19(1-3): 1782
Mahachoklertwattana, P.; Sanchez, J.; Grumbach, M.M.; Kaplan, S.L.; Rosenthal, S.M. 1993: N-Methyl-D-aspartate stimulates LHRH release via the NMDA receptor in an LHRH neuronal cell line. Pediatric Research 33(5 Suppl): S34
Morari, M.; O'connor, W.T.; Ungerstadt, U.; Fuxe, K. 1992: N-Methyl-D-aspartic acid differentially regulates dopamine, GABA and glutamate release in the dorsolateral striatum of the halothane anesthetized rat An in vivo microdialysis study. Society for Neuroscience Abstracts 18(1-2): 916
Yates, S.; Marnocha, P.; Huston, K.; Deutsch, S.; Spriggs, D. 1993: N-Methyl-L-arginine does not reduce cytotoxicity or alter gene expression in cells treated with tumor necrosis factor. Proceedings of the American Association for Cancer Research 34: 443
Estienne, M.J.; Harter Dennis, J.M.; Barb, C.R.; Hartsock, T.G.; Campbell, R.M.; Armstrong, J.D. 1994: N-Methyl-d,l-aspartate -induced growth hormone secretion in barrows Mechanism of action. Journal of Dairy Science 77(Suppl 1): 287
Petronis, A.; O'hara, K.; Barr, C.L.; Kennedy, J.L.; Van Tol, H.H.M. 1994: N-Mononucleotide polymorphism in the human D4 dopamine receptor gene. Human Genetics 93(6): 719
Yan, X.; Chua, M.-S.; Sun, H.; So, S. 2008: N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Cancer Letters 262(1): 133-142
Chu, J.J.; Xu, Y.C.; Ye, B.F. 1994: N-nitroso-compounds of pickles in the areas with high incidence of digestive cancers and their mutagenic effects. Zhonghua Yu Fang Yi Xue Za Zhi 28(4): 202-205
Schleicher, R.L.; Fallon, M.T.; Austin, G.E.; Zheng, M.; Zhang, M.; Collins, D.C. 1993: N-Nitroso-N-methylurea induction of prostate cancer in rats. Proceedings of the American Association for Cancer Research 34: 249
Xiang, Y.ejun; Chen, Jie; Schinazi, Raymond, F.; Zhao, Kang 1995: N-O diheterocyclic nucleosides Synthesis of 2-N-methyl-3-hydroxymethyl-1,2-isoxazolidinylthymidine. Tetrahedron Letters 36(40): 7193-7196
Crespo,G.; Rodriguez,I.; Martinez,O. 2008: N-P-K balance in a milk production system on a C nlemfuensis grassland and a biomass bank of P purpureum CT-115 clone. Multifunctional Grasslands In A Changing World, Volume 1: Xxi International Grassland Congress And Viii International Rangeland Congress, Hohhot, China, 29 E 5 Y: 4
Harrold, J.A.; Elliott, J.E.; Elliott, A.A. 1995: N-Pentanol block of rat brain RCK1 potassium channels expressed in Xenopus oocytes Comparison with block by external tetraethylammonium ions. Journal of Physiology (Cambridge) 489P: 59P
Harrold, J.A.; Elliott, J.R.; Elliott, A.A. 1996: N-Pentanol causes depolarizing shifts in the voltage dependence of both activation and inactivation of rat brain RCK4 fast-inactivating potassium channels expressed in Xenopus oocytes. Journal of Physiology (Cambridge) 491P: 89P
Arasappan, A.; Fraser Reid, B. 1995: N-Pentenyl furanosides Synthesis and glycosidation reactions of some galacto derivatives. Tetrahedron Letters 36(44): 7967-7970
Merritt, J.R.; Fraser Reid, B. 1992: N-Pentenylglycoside methodology for rapid assembly of homoglycans exemplified with the nonasaccharide component of a high-mannose glycoprotein. Journal of the American Chemical Society 114(21): 8334-8338
Matesic, L.; Locke, J.M.; Bremner, J.B.; Pyne, S.G.; Skropeta, D.; Ranson, M.; Vine, K.L. 2008: N-phenethyl and N-naphthylmethyl isatins and analogues as in vitro cytotoxic agents. Bioorganic and Medicinal Chemistry 16(6): 3118-3124
Kuo, E.A. 1995: N-Phenyl-2-cyano-3-hydroxy-propenamides. Official Gazette of the United States Patent and Trademark Office Patents 1174(3): 1925
Bourzat, J.D.; Capet, M.; Cotrel, C.; Guyon, C.; Manfre, F.; Roussel, G. 1994: N-Phenyl-N-alkoxycarbonylalkyl glycinamides, their preparation and the medicaments containing them. Official Gazette of the United States Patent and Trademark Office Patents 1169(3): 1738
Dostert, P.; Pevarello, P.; Heidempergher, F.; Varasi, M.; Bonsignori, A.; Roncucci, R. 1995: N-Phenylalkyl substituted alpha-amino carboxamide derivatives and process for their preparation. Official Gazette of the United States Patent and Trademark Office Patents 1171(3): 1804
Blough, H.A.; Soike, K.; Shannon, W.; Wyde, P.; Pavan Langston, E.D.nkel And, D. 1993: N-Phosphonoacetylaspartate An effective and safe broad spectrum antiviral. Antiviral Research 20(Suppl 1): 175
Bettarini, F.; Meazza, G.; La, P., P.; Zanardi, G.; Massimini, S.; Reggiori, F. 1996: N-Polyhalobenzyl-pyrazole carboxamides endowed with acaricidal and insecticidal activity. Official Gazette of the United States Patent and Trademark Office Patents 1188(5): 3723
Sterling, J.; Veinberg, A.; Lerner, D.; Goldenberg, W.; Levy, R.; Youdim, M.; Finberg, J. 1998: N-Propargyl-1-aminoindan and derivatives Highly selective and potent inhibitors of monoamine oxidase B. Journal of Neural Transmission Suppl 52: 301-305
Kimura, M.; Takabuchi, S.; Tanaka, T.; Murata, M.; Nishi, K.; Oda, S.; Oda, T.; Kanai, M.; Fukuda, K.; Kizaka-Kondoh, S.; Adachi, T.; Takabayashi, A.; Semenza, G.L.; Hirota, K. 2008: N-Propyl gallate activates hypoxia-inducible factor 1 by modulating intracellular oxygen-sensing systems. Biochemical Journal 411(1): 97-105
Cillo, C.; Cantile, M.; Mortarini, R.; Tiberio, C.; Barba, P.; Anichini, A.; Poupon, M.F. 1995: N-RAS mutation and p53 expression correlate to HOX gene expression in clonal melanoma populations isolated from a single human melanoma metastasis. Proceedings of the American Association for Cancer Research 36: 564
Wang, J.C.; Wong, P.M.C.; Chung, S.W. 1993: N-Ras oncogene mutation in agnogenic myeloid metaplasia. Blood 82(10 Suppl 1): 557A
Mor, A.; Keren, G.; Kloog, Y.; George, J. 2008: N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells. European Journal of Immunology 38(6): 1493-1502
Grant, P.; Veeranna; Takashashi, M.; Pant, H.C. 1995: N-SEC1/P67, a syntaxin binding proteins, is also a regulator of CDK5 in a multimeric complex bound to the neuronal cytoskeleton. Molecular Biology of the Cell 6(Suppl ): 376A
Peck, J.V.; Wysocki, R.J.; Uwaydah, I.M.; Cusack, N.J. 1997: N-Substituted 9-alkyladenines. Official Gazette of the United States Patent and Trademark Office Patents 1202(4): 3106
Steiner, G.; Unger, L.; Behl, B.; Teschendorf, H J. 1996: N-Substituted azabicyclo320heptane derivatives as neuroleptics, the preparation and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1186(4): 2817-2818
Buzzetti, F.; Crugnola, A.; Longo, A.; Brasca, M.G.; Ballinari, D. 1997: N-Substituted beta-aryl- and beta-heteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation. Official Gazette of the United States Patent and Trademark Office Patents 1200(5): 3556
Albaugh, P.; White, G.J.; Garst, M.E. 1995: N-Substituted derivatives of 3R,4R-ethyl- methyl-2-pyrrolidone. Official Gazette of the United States Patent and Trademark Office Patents 1178(4): 2396
Thogersen, H.; Hansen, B.S.; Peschke, B.; Hansen, T.K.; Andersen, K.E. 1998: N-Substituted naphthofused lactams. Official Gazette of the United States Patent and Trademark Office Patents 1215(1): 585-586
Ohnishi, M.; Tajima, S.; Nishiguchi, T.; Tsubata, K. 1998: N-Substituted phenylcarbamic acid derivatives, a process for production thereof, agricultural and horticultural fungicides, intermediates of the derivatives and a process for production thereof. Official Gazette of the United States Patent and Trademark Office Patents 1206(4): 3001
Porter, J.R.; Morphy, J.R.; Millican, T.A.; Beeley, N.R.A. 1996: N-Sulphonylamino derivatives of dipetide compounds as metalloproteinase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1187(4): 2883
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A. 1994: N-Terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma Investigation of plasma levels and molecular circulating form using radioimmunoassays for pro-atrial natriuretic peptide , pro-atrial natriuretic peptide and atrial natriuretic peptide. Clinical Science 87(3): 311-317
Yoshitomi, S.; Kurokawa, T.; Igarashi, K. 1996: N-Terminally truncated HST-1 is a platelet-increasing factor. Official Gazette of the United States Patent and Trademark Office Patents 1190(4): 2890
Haviv, F.; Fitzpatrick, T.D.; Swenson, R.E.; Nichols, C.J.; Mort, N.A. 1996: N-Terminus modified analogs of LHRH. Official Gazette of the United States Patent and Trademark Office Patents 1184(4): 2336-2337
Wegner, A.M.; Nebhan, C.A.; Hu, L.; Majumdar, D.; Meier, K.M.; Weaver, A.M.; Webb, D.J. 2008: N-wasp and the arp2/3 complex are critical regulators of actin in the development of dendritic spines and synapses. Journal of Biological Chemistry 283(23): 15912-15920
Sharma, A.K. 1996: N-acetonyl-substituted-amides. Official Gazette of the United States Patent and Trademark Office Patents 1187(4): 2824
Thayer, J.M.; Mirkes, P.E. 1994: N-acetoxy-2-acetylaminofluorene-induced apoptosis. Teratology 49(5): 383
Clark, J.B. 1998: N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Developmental Neuroscience 20(4-5): 271-276
Ebisu, T.; Rooney, W.D.; Graham, S.H.; Weiner, M.W.; Maudsley, A.A. 1993: N-acetyl aspartate as a marker of neuronal viability in kainate-induced epilepsy studied by magnetic resonance spectroscopic imaging. Society for Neuroscience Abstracts 19(1-3): 604
Ueda, H.; Matsumoto, M.; Nakano, M.; Li, J.Y.; Yoshida, Y.; Yanagihara, T. 1995: N-acetyl aspartate levels in delayed neuronal death in the hippocampus of the gerbil brain. Journal of Neurochemistry 64(Suppl 1): S13
Leshinsky, E.; Ribeiro, L.; Gage, D.A.; Kolodny, E.H. 1997: N-acetyl aspartoglutamate metabolism in brain Application to Canavan disease. Journal of Neurochemistry 69(Suppl ): S192
Yamada, M.; Kojima, N.; Paranjpe, A.; Att, W.; Aita, H.; Jewett, A.; Ogawa, T. 2008: N-acetyl cysteine (NAC)-assisted detoxification of PMMA resin. Journal of Dental Research 87(4): 372-377
Berk, M.; Copolov, D.; Dean, O.; Lu, K.; Jeavons, S.; Schapkaitz, I.; Anderson-Hunt, M.; Judd, F.; Katz, F.; Katz, P.; Ording-Jespersen, S.; Little, J.; Conus, P.; Cuenod, M.; Do, K.Q.; Bush, A.I. 2008: N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial. Biological Psychiatry 64(5): 361-368
Geudens, N.; Wuyts, W.A.; Rega, F.R.; Vanaudenaerde, B.M.; Neyrinck, A.P.; Verleden, G.M.; Lerut, T.E.; Van Raemdonck, D.E.M. 2008: N-acetyl cysteine attenuates the inflammatory response in warm ischemic pig lungs. Journal of Surgical Research 146(2): 177-183
Berk, M.; Copolov, D.L.; Dean, O.; Lu, K.; Jeavons, S.; Schapkaitz, I.; Anderson-Hunt, M.; Bush, A.I. 2008: N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial. Biological Psychiatry 64(6): 468-475
Janssens, A.R.; Schurewegh, Al; De Clerck, L.S.; Bridts, C.H.; De Backer, W.A.; Stevens, W.J. 1998: N-acetyl cysteine induced changes in oxygen radical production and glutathion levels in neutrophils of patients with chronic obstructive pulmonary diseases. Journal of Allergy and Clinical Immunology 101(1 Part 2): S114
Pahan, K.; Skeikh, F.G.; Namboodiri, A.M.S.; Singh, I. 1997: N-acetyl cysteine inhibits induction of NO production by endotoxin or cytokine stimulated rat peritoneal macrophages, astrocytes and C6 glial cells. Journal of Neurochemistry 69(Suppl ): S187
Parry, W.; Poovala, V.; Kanji, V.; Salahudeen, A. 1997: N-acetyl cysteine prevents cisplatin -nephrotoxicity in-vitro and in-vivo Role of glutathione. Journal of Investigative Medicine 45(1): 70A
Vasdev, S.; Wadhawan, S.; Ford, C.A.; Gadag, V. 1997: N-acetyl cysteine prevents fructose induced hypertension. Clinical Chemistry 43(6 Part 2): S193
Paranjpe, A.; Sung, E.C.; Cacalano, N.A.; Hume, W.R.; Jewett, A. 2008: N-acetyl cysteine protects pulp cells from resin toxins in vivo. Journal of Dental Research 87(6): 537-541
Parry, W.; Poovala, V.; Kanji, V.; Salahudeen, A. 1996: N-acetyl cysteine protects the kidney against cisplatin -toxicity in vitro and in vivo. Journal of the American Society of Nephrology 7(9): 1844
Morrissey, J.; Duan, L.; Klahr, S. 1996: N-acetyl cysteine treatment alters nuclear transcription factor activity and monocyte infiltration of the kidney during ureteral obstruction. Journal of the American Society of Nephrology 7(9): 1830
Hofbauer, J.; Fang Kircher, S.; Wiener, H.; Susani, M.; Steiner, G.; Marberger, M. 1995: N-acetyl neuraminic acids Key substances in renal calculogenesis?. Journal of Urology 153(4 Suppl): 350A
Kuratko, C.; Brinlee, R.; Pence, B. 1997: N-acetyl transferase activity is decreased in rats fed high fat diets containing menhaden oil. FASEB Journal 11(3): A578
Hanaya, R.; Kiura, Y.; Kurisu, K.; Sakai, N.; Serikawa, T.; Sasa, M. 2008: N-acetyl-L-aspartate activates hippocampal CA3 neurons in rodent slice preparations. Brain Research Bulletin 75(5): 663-667
Molony, D.A.; Patel, A.; Mehta, P. 1997: N-acetyl-L-cysteine abolishes apoptosis of ST-1 cells induced by nephrotoxicant pesticides. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 606A
Dorward, A.; Singh, G. 1996: N-acetyl-L-cysteine alters cell cycle progression in ovarian cancer cells of epithelial origin. FASEB Journal 10(6): A1288
Guijarro,L.G.; Mate,J.; Gisbert,J.P.; Perez-Calle,J.L.; Marin-Jimenez,I.; Arriaza,E.; Olleros,T.; Delgado,M.; Castillejo,M.S.; Prieto-Merino,D.; GonzalezLara,V.; Pena,A.S. 2008: N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis randomized, placebo-controlled pilot study. World Journal Of Gastroenterology: 18, 2851-2857
Torii, Y.; Saito, H.; Matsuki, N. 1994: N-acetyl-L-cysteine prevented release of 5-hydroxytryptamine from suncus small intestine induced by cisplatin. Japanese Journal of Pharmacology 64(Suppl 1): 285P
Yan, C.Y.I.; Ferrari, G.; Joyce, M.P.; Greene, L.A. 1994: N-acetyl-L-cysteine prevents apoptotic death of trophic-factor-deprived PC12 cells and sympathetic neurons. Society for Neuroscience Abstracts 20(1-2): 681
Thielemann, L.E.; Rosenblut, G. 1995: N-acetyl-L-cysteine prevents the increase in papillary DNA synthesis triggered by bromoethylamine-induced necrosis. Medical Science Research 23(6): 399-400
Oeda, T.; Henkel, R.; Nagai, A.; Schill, W.B.; Ohmori, H. 1997: N-acetyl-L-cysteine scavenges reactive oxygen species in human semen. International Journal of Andrology 20(Suppl 1): 16
Smith, C.V.; Blomkalns, A.L.; Rogers, L.K.; Tamura, T.; Tonoki, H.; Hansen, T.N. 1995: N-acetyl-P-benzoquinone imine toxicity in Chinese hamster ovary cells with genetically modified glutathione reductase activities. FASEB Journal 9(4): A694
Lu, X.C.M.; Tang, Z.; Liu, W.; Lin, Q.; Slusher, B.S. 1998: N-acetyl-aspartyl-glutamate protects against focal cerebral ischemia in a rat model of MCAO. Society for Neuroscience Abstracts 24(1-2): 581
Miadonna, A.; Milazzo, N.; Cottini, M.; Tedeschi, A. 1994: N-acetyl-aspartyl-glutamic acid inhibits very late antigen-induced nasal neutrophilia and eosinophilia. Journal of Allergy and Clinical Immunology 93(1 Part 2): 272
Stojcheva Taneva, O.; Ivanovski, N.; Grozdanovski, R.; Polenakovic, M. 1995: N-acetyl-beta-D-glucosaminidase and B-2 microglobulin in diabetics in relation to microangiopathy. Journal of the American Society of Nephrology 6(3): 456
Stojanov, M.; Mehanovic Hanjalic, J.; Sanicanin, Z. 1994: N-acetyl-beta-D-glucosaminidase and glutathione-S-transferase as indicators of cisplatin nephrotoxicity. Clinical Chemistry 40(6): 1125
Tomasiak, M.M.; Tomasiak, M.; Zietkowski, Z.; Skiepko, R.; Bodzenta-Lukaszyk, A. 2008: N-acetyl-beta-hexosaminidase activity in asthma. International Archives of Allergy and Immunology 146(2): 133-137
Robinson, K.A.; Hensley, K.; Stewart, C.A.; Pye, Q.; Grammas, P.; Floyd, R.A. 1998: N-acetyl-cysteine and phenyl-tert-butyl nitrone prevent IL-1beta, H2O2, and hyperosmotic activation of p38 and their inactivation of phosphatases in primary rat glial cells. Society for Neuroscience Abstracts 24(1-2): 864
De Vries, N.; De Flora, S. 1993: N-acetyl-l-cysteine. Journal of Cellular Biochemistry. Supplement 17f: 270-277
Lindner, H.A.; Täfler-Naumann, M.; Röhm, K.-H. 2008: N-acetylamino acid utilization by kidney aminoacylase-1. Biochimie 90(5): 773-780
Miller, S.L.; Daikhin, Y.; Yudkoff, M.; Duncan, I. 1997: N-acetylaspartate Levels in brain regions during development and implications regarding its cellular specificity. Journal of Neurochemistry 69(Suppl ): S175
Mehta, V.; Razavi, P.; Tamjidi, P.; Datwani, A.; Scharaf, R.; Wroblewska, B.; Namboodiri, M.A.A. 1995: N-acetylaspartate as an acetyl source for lipid synthesis in cultured astrocytes from 8 day old rats. Society for Neuroscience Abstracts 21(1-3): 564
Tsai, G.; Coyle, J.T. 1995: N-acetylaspartate in neuropsychiatric disorders. Progress in Neurobiology 46(5): 531-540
Wroblewska, B.; Surin, A.; Pshenichkin, S.; Wroblewski, J.T.; Neale, J.H. 1996: N-acetylaspartylglutamate as a selective agonist of mGluR3. Neuropharmacology 35(6): A34
Yourick, D.L.; Koenig, M.L.; Long, J.B. 1998: N-acetylaspartylglutamate attenuates hypoxia- and NMDA-induced cell death in spinal cord cultures. Society for Neuroscience Abstracts 24(1-2): 463
Burlina, A.B.; Ferrari, V.; Dionisi Vici, C.; Zacchello, F.; Burlina, A.P. 1994: N-acetylaspartylglutamate in urine and CSF in Canavan Disease. Pediatric Research 35(4 Part 2): 379A
Neale, J.H.; Wroblewska, B. 1993: N-acetylaspartylglutamate inhibits cyclic GMP formation in cerebellar granule cells. Society for Neuroscience Abstracts 19(1-3): 1135
Long, J.B.; Yourick, D.L.; Meyerhoff, J.L. 1998: N-acetylaspartylglutamate protects against dynorphin A-induced ischemic spinal cord injury in rats. Society for Neuroscience Abstracts 24(1-2): 463
Burlina, A.P.; Skaper, S.D.; Mazza, M.R.; Ferrari, V.; Lcon, A.; Burlina, A.B. 1994: N-acetylaspartylglutamate selectively inhibits neuronal responses to N-methyl-D-aspartate. Society for Neuroscience Abstracts 20(1-2): 247
Fuhrman, S.; Neale, J.H. 1993: N-acetylaspartylglutamate studied in medial prefrontal cortex in rats using in vivo microdialysis. Society for Neuroscience Abstracts 19(1-3): 920
Passani, L.A.; Vonsattel, J.P.G.; Carter, R.E.; Coyle, J.T. 1996: N-acetylaspartylglutamate, N-acetylaspartate and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntingtons and Alzheimers disease. Society for Neuroscience Abstracts 22(1-3): 204
Jang, I.J.; Shin, S.G.; Yim, D.S.; Woo, J.I.; Lee, S.W.; Kim, S.H. 1993: N-acetylation and oxidation capacities in Korean patients with bladder cancer. Clinical Pharmacology and Therapeutics 53(2): 158
Wong, K.P.; Sit, K.H.; Lim, B.G. 1992: N-acetylation in human liver and human cells in culture. Acta Cytologica 36(5): 845
Muimo, R.; Isaac, R.E. 1993: N-acetylation of 5-HT is a major metabolic pathway in nematodes and is developmentally regulated in Caenorhabditis elegans. Journal of Cellular Biochemistry Suppl 1993(17 Part C): 117
Maehler, S.; Schlattjan, J.H.; Foellmann, W.; Degen, G.H. 1996: N-acetylation of benzidine in cultured porcine urinary bladder epithelial cells and ovine seminal vesicle cells. Naunyn-Schmiedeberg's Archives of Pharmacology 353(4): R112
Asada, M.; Goto, H.; Abe, M.; Tachibana, T.; Suzuki, Y.; Suzuki, T. 1997: N-acetylation polymorphism in Japanese patients with sarcoidosis. Pharmacogenetics 7(4): 341-344
Martell, K.J.; Weber, W.W. 1993: N-acetylation polymorphism in liver and pancreas of inbred rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(5): 965-966
Kaku, H.; Shibuya, N.; Xu, P.; Aryan, A.P.; Fincher, G.B. 1997: N-acetylchitooligosaccharides elicit expression of a single -beta-glucanase gene in suspension-cultured cells from barley. Physiologia Plantarum 100(1): 111-118
Kuchitsu, K.; Shibuya, N. 1994: N-acetylchitooligosaccharides, specific fungal elicitor for defense responses, induce transient generation of active oxygen species in suspension-cultured rice cells. Asada, K, Yoshikawa, T International Congress Series; Frontiers of reactive oxygen species in biology and medicine 255-256
Moldéus, P.; Cotgreave, I.A. 1994: N-acetylcysteine. Methods in Enzymology 234: 482-492
Cotgreave, I.A. 1997: N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Advances in Pharmacology 38: 205-227
Rigberg, D.A.; Blinman, T.A.; Lane, J.S.; Kim, F.S.; Hines, O.J.; Mcfadden, D.W.; Chandler, C.F. 1998: N-acetylcysteine abrogates the systemic response to murine intestinal ischemia/reperfusion. Gastroenterology 114(4 Part 2): A1420
Poptic, E.J.; Chai, Y.C.; Faruqi, R.; Chisolm, G.M.; Dicorleto, P.E. 1994: N-acetylcysteine alters glutathione levels and redox state in human umbilical vein endothelial cells Effect on NF-kappa-B binding activity. Molecular Biology of the Cell 5(Suppl ): 372A
Cortelezzi, A.; Sarina, B.; Cattaneo, C.; Cristiani, S.; Silvestris, I.; Motta, M.; Ibatici, A.; Maiolo, A.T. 1998: N-acetylcysteine and all-trans retinoic acid on hemopoiesis in myelodysplastic syndromes Effect on apoptosis and clonogenic potential. Blood 92(10 Suppl 1 Part 1-2): 631A
Nakano, H.; Nagasaki, H.; Yoshida, K.; Kigawa, G.; Fujiwara, Y.; Kitamura, N.; Kuzume, M.; Takeuchi, S.; Sasaki, J.; Shimura, H.; Yamaguchi, M.; Kumada, K. 1998: N-acetylcysteine and anti-ICAM-1 monoclonal antibody reduce ischemia-reperfusion injury of the steatotic rat liver. Transplantation Proceedings 30(7): 3763
Betts, W.H.; Zhang, Y.; Rokicinski, M.; Horowitz, J.D. 1993: N-acetylcysteine and captopril inhibit but S-nitroso-N-acetylcysteine stimulates human neutrophil free radical production. Circulation 88(4 Part 2): I90
Vivot, C.; Stump, D.D.; Schwartz, M.E.; Theise, N.D.; Miller, C.M. 1993: N-acetylcysteine attenuates cold ischemia/reperfusion injury in the isolated perfused rat liver. Transplantation Proceedings 25(2): 1983-1984
Sen, C.K.; Rankinen, T.; Vaisanen, S.; Rauramaa, R. 1994: N-acetylcysteine attenuates exercise associated blood glutathione oxidation. Medicine and Science in Sports and Exercise 26(5 Suppl): S132
Demols, A.; Van Laethem, J.L.; Quertinmont, E.; Louis, H.; Le Moine, O.; Deviere, J. 1998: N-acetylcysteine decreases chemo- and cytokine release and pancreatitis severity in mice. Digestion 59(3): 230
Koide, Y.ji; Dalle Lucca, Jurandir; Scicli, A.G.illermo 1996: N-acetylcysteine decreases neointima formation after balloon injury of the rat carotid artery. Circulation 94(8): I403-I404
Vosters, O.; Beuneu, C.; Goldman, M.; Verhasselt, V.ér. 2008: N-acetylcysteine derivative inhibits CD40-dependent proinflammatory properties of human pancreatic duct cells. Pancreas 36(4): 363-368
Brisseau, G.F.; Marshall, J.C.; Cheung, P.Y.C.; Rotstein, O.D. 1993: N-acetylcysteine differentially modulates macrophage activation by lipopolysaccharides. Surgical Forum 44: 16-18
Pirazzi, B.; Gonzalez, P.; Avakian, E.; Fitzovich, D.; Collazo, V.; Mass, H. 1995: N-acetylcysteine diminishes vascular injury produced by carotid artery angioplasty in rabbits. FASEB Journal 9(3): A343
Haase, M.; Haase-Fielitz, A.; Ratnaike, S.; Reade, M.C.; Bagshaw, S.M.; Morgera, S.; Dragun, D.; Bellomo, R. 2008: N-Acetylcysteine does not artifactually lower plasma creatinine concentration. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 23(5): 1581-1587
Johnson, D.; Simone, C.; Derewlany, L.O.; Byrne, B.; Koren, G. 1995: N-acetylcysteine does not cross the human term placenta. FASEB Journal 9(4): A693
Khawli, F.A.; Stokic, D.S.; Koch, S.M.; Leis, A.A.; Reid, M.B. 1994: N-acetylcysteine does not inhibit high-frequency muscle fatigue in humans. FASEB Journal 8(4-5): A57
Vercelino, R.; Tieppo, J.; Dias, A.S.õe.; Marroni, C.áu.A.; Garcia, E.; Meurer, L.; Picada, J.N.; Marroni, N.P. 2008: N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome. Basic and Clinical Pharmacology and Toxicology 102(4): 370-376
Lopez, B.L.; Snyder, J.W.; Birenbaum, D.S.; Ma, X.I. 1998: N-acetylcysteine enhances endothelium-dependent vasorelaxation in the isolated rat mesenteric artery. Annals of Emergency Medicine 32(4): 405-410
Roberts, R.L.; Ank, B.J.; Falkner, S.; Stiehm, E.R. 1993: N-acetylcysteine enhances the cytotoxicity of neutrophils from normal adults and immunodeficient patients. Clinical Research 41(1): 89A
Beloqui, O.; Prieto, J.; Suarez, M.; Gil, B.; Qian, C.; Garcia, N.; Civeira, P. 1993: N-acetylcysteine enhances the response to lymphoblastoid alpha-interferon in chronic hepatitis C A pilot study. Journal of Hepatology 18(Suppl 1): S51
Giorgi, D.F.; Lobel, D.; Morasco, R.; Shih, R.S.; Meggs, W.J.; Goldfrank, L.R.; Hoffman, R.S. 1994: N-acetylcysteine for pennyroyal oil toxicity. Veterinary and Human Toxicology 36(4): 358
Sisillo,E.; Ceriani,R.; Bortone,F.; Juliano,G.; Salvi,L.; Veglia,F.; Fiorentini,C.; Marenzi,G. 2008: N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery a prospective, randomized, clinical trial. Critical Care Medicine: 1, 81-86
Gillissen, A.; Jaworska, M.; Wiethege, T.; Siegfried, W.; Schultze Werninghaus, G. 1994: N-acetylcysteine functions as an effective glutathione precursor in vitro and in vivo. Atemwegs- und Lungenkrankheiten 20(8): 468-470
Devlin, J.; Ellis, A.; Mcpeake, J.; Wendon, J.; Williams, R. 1994: N-acetylcysteine improves ICG clearance in addition to systemic haemodynamics during severe hepatic dysfunction. Hepatology 20(4 Part 2): 123A
Andrews, N.P.; Husain, S.; Prasad, A.; Husain, M.; Mincemoyer, R.; Panza, J.A.; Cannoni, R.O.I.; Quyyumi, A.A. 1997: N-acetylcysteine improves coronary vascular endothelial dysfunction. Journal of the American College of Cardiology 29(2 Suppl A): 444A
Tsuyuki, S.; Yamauchi, A.; Nakamura, H.; Nakamura, Y.; Kinoshita, K.; Gomi, T.; Kawai, Y.; Hirose, T.; Furuke, K.; Ikai, I.; Ohmori, K.; Yamaoka, Y.; Inamoto, T. 1998: N-acetylcysteine improves cytotoxic activity of cirrhotic rat liver-associated mononuclear cells. International Immunology 10(10): 1501-1508
Zala, G.; Wirth, H.P.; Schwery, S.; Flury, R.; Wurst, J.; Meyenberger, C.; Ammann, R. 1994: N-acetylcysteine improves eradication of H pylori by omeprazole/amoxicillin in cigarette smokers. Gastroenterology 106(4 Suppl): A216
Lindstrom, M.; Lundback, B.; Lundqvist, A.; Jonsson, E.; Sandstrom, T. 1996: N-acetylcysteine improves quality of life in chronic bronchitis. European Respiratory Journal Suppl 9(23): 305S-306S
Holt, S.; Marley, R.; Fernando, B.; Moore, K. 1998: N-acetylcysteine improves renal function in the hepatorenal syndrome. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 132A
Colombo, A.A.; Bernasconi, P.; Alessandrino, E.P.; Martinelli, G.; Biaggi, G.; Bernasconi, C. 1996: N-acetylcysteine in the treatment of acute graft versus host disease. Blood 88(10 Suppl 1 Part 1-2): 261B
Uthman, B.M.; Hurd, R.W.; Helveston, W.R.; Malone, J.E.; Wilder, B.J. 1995: N-acetylcysteine in the treatment of five siblings with hereditary spinocerebellar ataxia. Neurology 45(4 Suppl 4): A185-A186
Hurd, R.W.; Wilder, B.J.; Pippenger, C.E.; Uthman, B.M. 1995: N-acetylcysteine in the treatment of neurodegenerative disease Eighteen-month follow-up in patients with progressive myoclonus epilepsy. Neurology 45(4 Suppl 4): A181
Uzunalimoglu, O.; Cinar, K.; Erekul, S.; Bozkaya, H.; Bozdayi, A.M.; Koc, O.; Yurdaydin, C. 1998: N-acetylcysteine in thioacetamide induced toxic hepatitis in rats. Hepatology 28(4 Part 2): 630A
Wilder, B.J.; Hurd, R.W.; Uthman, B.M. 1994: N-acetylcysteine in treatment of neurodegenerative disease with altered superoxide dismutase activity. Neurology 44(4 Suppl 2): A178
Arora, P.; Lucchesi, P.A.; Wurster, R.D. 1998: N-acetylcysteine inhibits growth of astrocytoma cells. Proceedings of the American Association for Cancer Research 39: 120
Lojeski, E.W.; Haney, J.A.; Karan, S.M. 1995: N-acetylcysteine is ineffective in the treatment or prophylaxis of malignant hyperthermia in swine. Anesthesiology 83(3A): A353
Yan, C.Y.I.; Greene, L.A. 1997: N-acetylcysteine maintains PC12 cell survival through activation of the Ras pathway. Society for Neuroscience Abstracts 23(1-2): 1718
Steinberg, E.N. 1996: N-acetylcysteine may improve clinical outcome in acute alcoholic hepatitis. Gastroenterology 110(4 Suppl): A1334
Gilman, A.; Spero, D.E. 1993: N-acetylcysteine methyl ester An efficient sulfur transfer agent. Tetrahedron Letters 34(11): 1751-1752
Barrios, V.; Calderon, A.; Palma, J.L.; Navarro, J.; Asin, E.; Ruilope, L.M.; Lahera, V. 1997: N-acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in a smoker hypertensive population. Journal of the American College of Cardiology 29(2 Suppl A): 189A-190A
Primiano, M.; Palm, D.; Johanson, C.; Knuckey, N.W. 1993: N-acetylcysteine prevents hippocampal neuronal death induced by transient cerebral ischemia. Society for Neuroscience Abstracts 19(1-3): 883
Lee, L.A.; Prescott, W.; Picco, M.; Scheffel, U.A.; Finley, P. 1997: N-acetylcysteine prolongs survival from fulminant hepatitis by inhibiting apoptosis. Hepatology 26(4 Part 2): 366A
Zhang-Feng-Xiang; Chen-Ming-Long; Yang-Bing; Chen-Hong-Wu; Cao-Ke-Jiang 2008: N-acetylcysteine promoted aging through adjusting expression of cell cycle related protein in neonatal SD rat cardiomyocytes. Zhonghua Xinxueguanbing Zazhi 36(2): 146-150
Vendemiale, G.; Grattagliano, I.; Didonna, D.; Altomare, E. 1998: N-acetylcysteine protects hepatic mitochondria from oxidative alterations in bile duct ligated rats. Journal of Hepatology 28(Suppl 1): 78
Hess, D.C.; Wakade, M.; Melvin, J.; Sprinkle, A.; Carroll, J.; Sekul, E. 1997: N-acetylcysteine reduces infarct size in a transient middle cerebral artery occlusion model. Stroke 28(1): 257
Garfinkel, M.R.; Ballard, T.; Opara, E.C. 1996: N-acetylcysteine reduces intralipid-induced glutathione depletion. Gastroenterology 110(4 Suppl): A802
Wright, R.O.; Magnani, B.; Shannon, M.W.; Woolf, A.D. 1996: N-acetylcysteine reduces methemoglobin An in vitro model. Pediatric Research 39(4 Part 2): 164A
Wright, R.O.; Magnani, B.; Shannon, M.W.; Woolf, A.D. 1997: N-acetylcysteine reduces methemoglobin in an in vitro model of glucose-6-phosphate dehydrogenase. Pediatric Research 41(4 Part 2): 63A
Mohanraj, P.; Diaz, P.T.; Clanton, T.L. 1996: N-acetylcysteine reduces the loss of contractile function in severely hypoxic skeletal muscle. FASEB Journal 10(3): A2
Breithaupt, T.; Eylar, E.H.; Baez, I.; Vasquez, A.; Colon Martinez, S.; Rodriguez, J.; Kesseler, M. 1996: N-acetylcysteine reverses the suppressed mitogenic responses of CD4+ and CD8+ T cells from aged rhesus monkeys. FASEB Journal 10(6): A1320
Silva, L.A.; Silveira, P.C.L.; Pinho, Céber.A.; Tuon, T.; Dal Pizzol, F.; Pinho, R.A. 2008: N-acetylcysteine supplementation and oxidative damage and inflammatory response after eccentric exercise. International Journal of Sport Nutrition and Exercise Metabolism 18(4): 379-388
Bagnicka,E.; Jozwik,A.; Strzakowska,N.; Sliwa-Jozwik,A.; Krzyzewski,J.; Koataj,A. 2008: N-acetylcysteine supplementation may affect somatic cell count in goat milk. Archiv Fur Tierzucht: 6, 582-587
Pizzulli, L.; Ewig, S.; Hagendorff, A.; Manz, M.; Luederitz, B. 1994: N-acetylcysteine to prevent nitroglycerin tolerance hemodynamic assessment and neurohormonal counterregulation. European Heart Journal 15(ABSTR Suppl ): 16
Morissey, J.; Tolley, T.; Klahr, S. 1998: N-acetylcysteine treatment affects monocyte adhesion. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 482A
Bryne, M.; Rye, P.D. 1997: N-acetylgalactosamine containing glycoconjugates and the invasive and metastatic capacity of melanoma cell lines. Tumor Biology 18(Suppl 2): 75
IIda, S.I.; Yamamoto, K.; Sano, Y.; Irimura, T. 1997: N-acetylgalactosamine transfer to MUC-2 tandem repeat peptides by lysates of LS174T colon carcinoma cell. Glycoconjugate Journal 14(6): 774-775
Wong, C H. 1996: N-acetylgalactosaminyl or N-acetylglucosaminyl transfer using N-acetylglucosaminyl-1-phosphate or N-acetylgalactosaminyl-1-phosphate as precursor and glycosyl-nucleotide regeneration. Official Gazette of the United States Patent and Trademark Office Patents 1186(2): 1176
Sato, T.; Kobata, A.; Aoki, N.; Matsuda, T.; Furukawa, K. 1993: N-acetylgalactosaminylation of sugar chains regulated by lactogenic hormones in bovine mammary epithelial cell glycoproteins. Cell Structure and Function 18(6): 616
Scocca, J.; Zou, J.; Krag, S.S. 1992: N-acetylglucosamine-1-phosphate transferase of Chinese hamster ovary cells is stably expressed in Schizosaccharomyces pombe and can functionally replace the Schizosaccharomyces pombe gene. Glycobiology 2(5): 482
Law, M.P.; Lund, C.V.; Toler, R.A.; Luhm, M.J.; Goode, C.A. 1997: N-acetylglucosaminidase activity in eggs of Ascidia ceratodes. FASEB Journal 11(9): A1159
Marschall, H.U.; Wietholtz, H.; Goetze, U.; Roder, G.; Matern, H.; Sjovall, J.; Matern, S. 1992: N-acetylglucosaminides are major urinary metabolites of orally given ursodeoxycholic acid in healthy humans. Hepatology 16(4 Part 2): 257A
Taniguchi, N.; Nishikawa, A.; Yamaguchi, N. 1998: N-acetylglucosaminyl transferase gene coding therefor and process for production thereof. Official Gazette of the United States Patent and Trademark Office Patents 1206(2): 1350
Yamamoto, H.; Kersey, D.; Akama, K.; Nishikawa, A.; Taniguchi, N.; Moskal, J. 1994: N-acetylglucosaminyltransferase III and V mRNA expression in human brain tumors. Proceedings of the American Association for Cancer Research 35: 214
Akama, R.; Sato, Y.; Kariya, Y.; Isaji, T.; Fukuda, T.; Lu, L.; Taniguchi, N.; Ozawa, M.; Gu, J. 2008: N-acetylglucosaminyltransferase IIi expression is regulated by cell-cell adhesion via the E-cadherin-catenin-actin complex. Proteomics 8(16): 3221-3228
Pierce, J.M.; Shoreibah, M.G.; Adler, B.S.; Fregien, N.L. 1997: N-acetylglucosaminyltransferase V gene. Official Gazette of the United States Patent and Trademark Office Patents 1195(2): 1166
Yang, X.; Li, J.; Geng, M. 2008: N-acetylglucosaminyltransferase V modifies TrKA protein, regulates the receptor function. Cellular and Molecular Neurobiology 28(5): 663-670
Hession,A.O.; Esrey,E.G.; Croes,R.A.; Maxwell,C.A. 2008: N-acetylglutamate and N-acetylaspartate in soybeans , maize , and other foodstuffs. Journal of Agricultural and Food Chemistry 56: 9121-9126
Roer, R.D.; Butler, K.D. 1997: N-acetylhexosaminidase activity in the postecdysial cuticle of the blue crab - a role in the initiation of mineralization. American Zoologist 37(5): 140A
Amorelli, B.; Yang, C.; Rempel, B.; Withers, S.G.; Knapp, S. 2008: N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines. Bioorganic and Medicinal Chemistry Letters 18(9): 2944-2947
Ihle, E.C.; Schwartz, E.A. 1994: N-acetylhistidine buffers pH during synaptic transmission in the Bufo marinus retina. IOVS Investigative Ophthalmology and Visual Science 35(4): 1363
Kragl, U.; Kittelmann, M.; Ghisalba, O.; Wandrey, C. 1995: N-acetylneuraminic acid From a rare chemical from natural sources to a multikilogram enzymatic synthesis for industrial application. Legoy, M -D , Thomas, D Annals of the New York Academy of Sciences; Enzyme engineering XII 300-305
Han, Y.; Kim, K.; Shim, J-Young.; Park, C.; Song, J-Young.; Yun, Y-Sook. 2008: N-acetylphytosphingosine enhances the radiosensitivity of lung cancer cell line NCI-H460. Molecules and Cells 25(2): 224-230
Leblanc, M.; Pichette, V.; Madore, F.; Ouimet, D.; Geadah, D.; Cardinal, J. 1995: N-acetylprocainamide intoxication with torsade de pointes treated by high dialysate flow rate continuous arteriovenous hemodiafiltration. Critical Care Medicine 23(3): 589-593
Ambrosone, C.B.; Freudenheim, J.L.; Marshall, J.R.; Graham, S.; Vena, J.E.; Brasure, J.R.; Michalek, A.M.; Bowman, E.D.; Harrington, A.M.; Shields, P.G. 1995: N-acetyltransferase , cigarette smoking, and breast cancer risk. Proceedings of the American Association for Cancer Research 36: 283
Roemer, H.C.; Weistenhofer, W.; Lohlein, D.; Geller, F.; Blomeke, B.; Golka, K. 2008: N-acetyltransferase 1 in colon and rectal cancer cases from an industrialized area. Journal of Toxicology and Environmental Health. Part A 71(13-14): 902-905
Juhanson, P.; Kepp, K.; Org, E.; Veldre, G.; Kelgo, P.; Rosenberg, M.; Viigimaa, M.; Laan, M. 2008: N-acetyltransferase 8, a positional candidate for blood pressure and renal regulation: resequencing, association and in silico study. Bmc Medical Genetics 9: 25
Zheng, W.; Deitz, A.; Campbell, D.; Wen, W.Q.; Sellers, T.; Cerhan, J.; Folsom, A.; Hein, D. 1998: N-acetyltransferase I genetic polymorphisms, cigarette smoking, well-done meat intake, and the risk of breast cancer. Anticancer Research 18(5C): 3887
Pronko, P.; Lindros, K.O.; Eriksson, C.J.P. 1998: N-acetyltransferase activity in the alcohol preferring AA and alcohol avoiding ANA rat lines. Alcoholism Clinical and Experimental Research 22(3 ABSTR Suppl ): 186A
Jones, R.F.; Debiec Rychter, M.; Schut, H.J.; Morse, P.; Haas, G.P.; Wang, C.Y. 1998: N-acetyltransferase expression and heterocyclic amine adduct formation in human prostate. Proceedings of the American Association for Cancer Research 39: 635
Chern, H.D.; Persad, R.A.; Fleming, C.M.; Bryant, J.L.; Romkes Sparks, M.; Sibley, G.A.; Smith, P.J.B.; Branch, R.A. 1995: N-acetyltransferase slow acetylator phenotype increases susceptibility to occupational related aggressive bladder cancer. Proceedings of the American Association for Cancer Research 36: 121
Hanna, P.E. 1994: N-acetyltransferases, O-acetyltransferases, and N,O-acetyltransferases: enzymology and bioactivation. Advances in Pharmacology 27: 401-430
Van Goudoever, J.B.; Sulkers, E.J.; Broerse, H.M.; Carnielli, V.P.; Sauer, P.J.J. 1992: N-acetyltyrosine and acetylcystine An alternative to low intake of tyrosine and cystine in neonatal total parenteral nutrition ?. Pediatric Research 32(5): 626
Vecchietti, V.; Colle, R.; Dondio, G.; Giardina, G. 1994: N-acryl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals. Official Gazette of the United States Patent and Trademark Office Patents 1168(4): 2571
Nakamura, N.; Ohkawa, N.; Oshima, T.; Miyamoto, M.; IIjima, Y. 1996: N-acryloylpiperazine compounds. Official Gazette of the United States Patent and Trademark Office Patents 1190(3): 2068-2069
Nakamura, N.; Ohkawa, N.; Oshima, T.; Miyamoto, M.; IIjima, Y. 1994: N-acryloylpiperazine derivatives, their preparation and their use of paf antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1168(5): 3333
Tjoeng, F.S.; Toth, M.V. 1998: N-acyl beta amino acid derivatives useful as platelet aggregation inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1206(3): 2197
Della, V., F.; Lorenzi, S.; Samson, J.C.J.J.; Della, V., F. 1996: N-acyl derivatives of aminoalcohols active as local autacoids and useful in the therapy of autoimmune processes. Official Gazette of the United States Patent and Trademark Office Patents 1185(2): 1197
Della, V., F.; Lorenzi, S.; Marcolongo, G. 1997: N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having neuroimmunogenic origin. Official Gazette of the United States Patent and Trademark Office Patents 1197(2): 1155-1156
Drauz, K.; Knaup, G.; Groeger, U. 1996: N-acyl dipeptides and their compositions. Official Gazette of the United States Patent and Trademark Office Patents 1188(2): 1271-1272
Frey, C.; Griffith, O.W. 1996: N-acyl guanidines; A new class of nitric oxide synthase inhibitors. FASEB Journal 10(6): A1399
Heys, S.J.D.; Mullen, R.; Gilbert, P.; Allison, D.G. 1997: N-acyl homoserine lactones and bacterial biofilms. Journal of Pharmacy and Pharmacology 49(Suppl 4): 6
Capet, M.; Dubroeucq, M C. 1997: N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders. Official Gazette of the United States Patent and Trademark Office Patents 1197(5): 3272-3273
Crudden, J.J. 1996: N-acyl sarcosinates Effective, ecofriendly adjuvants for pesticide formulation. Abstracts of Papers American Chemical Society 211(1-2): AGRO 194
Lombardo, L.J. 1995: N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents. Official Gazette of the United States Patent and Trademark Office Patents 1179(3): 1829
Keavy, D.J.; Parker, M.F.; Mattson, R.J.; Johnson, G. 1998: N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics. Official Gazette of the United States Patent and Trademark Office Patents 1210(3): 2632-2633
Andrasi, F.; Berzsenyi, P.; Botka, P.; Farkas, S.; Goldschmidt, K.; Hamori, T.; Korosi, J.; Moravcsik, I.; Tarnawa, I. 1996: N-acyl-2,3-benzodiazepine derivatives and a method of treating spasms of the skeletal musculature therewith. Official Gazette of the United States Patent and Trademark Office Patents 1186(4): 2804
Andrasi, F.; Berzsenyl, P.; Botka, P.; Farkas, S.; Goldschmidt, K.; Hamori, T.; Korosi, J.; Moravcsik, I.; Tarnawa, I. 1997: N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic neurodegenerative disorders. Official Gazette of the United States Patent and Trademark Office Patents 1199(3): 1928
Andrasi, F.; Berzsenyi, P.; Botka, P.; Farkas, S.; Goldschmidt, K.; Hamori, T.; Korosi, J.; Moravcsik, I.; Tarnawa, I. 1996: N-acyl-2,3-benzoidazepine derivatives, pharmaceutical compositions containing them and process for preparing same. Official Gazette of the United States Patent and Trademark Office Patents 1186(3): 2018-2019
Zenker, L.; Wunderlich, H.; Lohmann, D.; Rostock, A.; Siegemund, C.; Valdman, A.V.; Voronina, T.A.; Rachmankulova, I.C.; Glozman, O.M.; Garibova, T.L.; Mescerjakova, L.M.; Zmurenko, L.A.; Seredenin, S.B.; Rozancev, G.G. 1995: N-acyl-4-phenyl-pyrrolidin-2-ones and method for preparing. Official Gazette of the United States Patent and Trademark Office Patents 1177(3): 1769
Schmidlin, T.; Zbinden, P.; Buehlmayer, P. 1997: N-acyl-N-heterocyclylalkylamino acid compounds and method of use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1197(3): 1909
Paik, S.; White, E.H. 1994: N-acyl-N-nitrosoamino acids and peptides. Tetrahedron Letters 35(42): 7731-7734
Takematsu, T.; Kume, T.; Komata, T.; Suzuki, K.; Ikeda, Y.; Kawamura, M.; Mori, K. 1996: N-acyl-N-phenylmaleamic acid derivatives, methods of producing same, and herbicides containing same as effective components. Official Gazette of the United States Patent and Trademark Office Patents 1185(4): 2705
Takematsu, T.; Komata, T.; Kume, T.; Suzuki, K.; Kawamura, M.; Shirakawa, Y.; Mori, K. 1995: N-acyl-N-phenyltetrahydrophthalamic acid derivatives, methods of producing same, and herbicides containing same as effective components. Official Gazette of the United States Patent and Trademark Office Patents 1180(3): 1783
Schmidlin, T.; Zbinden, P.; Buehlmayer, P. 1996: N-acyl-N-quinolinyl or isoquinounyl alkylamino acids compositions and method of use. Official Gazette of the United States Patent and Trademark Office Patents 1185(2): 1204-1205
Metzger, J.; Wiesmueller, K H.; Jung, G. 1997: N-acyl-S- cysteines, their preparation and their use as intermediates for the preparation of synthetic immuno-adjuvants and synthetic vaccines. Official Gazette of the United States Patent and Trademark Office Patents 1205(4): 3097
Mattson, R.J.; Keavy, D.J.; Parker, M.F.; Johnson, G. 1997: N-acyl-cycloalkylamine derivatives as melatonergics. Official Gazette of the United States Patent and Trademark Office Patents 1194(3): 1959
Ptchelintsev, D. 1997: N-acyl-ethylene-triacetic acids. Official Gazette of the United States Patent and Trademark Office Patents 1197(3): 1912
Wood, D.W.; Pierson, E.A.; Cannon, J.A.; Pierson, L.S.IIi 1997: N-acyl-homoserine lactone mediates intra- and interpopulation signaling in the rhizosphere. Abstracts of the General Meeting of the American Society for Microbiology 97: 310
Morishima, H.; Koike, Y.; Nakano, M.; Atsuumi, S.; Tanaka, S.; Matsuyama, K. 1996: N-acylamino acid derivatives and their use. Official Gazette of the United States Patent and Trademark Office Patents 1185(2): 1243-1244
Boeckh, J.; Hoever, F.P.; Krueger, B.W.; Nentwig, G.; Roeder, K. 1996: N-acylated 2- -piperidines A new class of insect and tick repellents. Abstracts of Papers American Chemical Society 212(1-2): AGRO 20
Bazan, N.G.; Gomez, J.A. 1996: N-acylated 4-hydroxphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them. Official Gazette of the United States Patent and Trademark Office Patents 1190(2): 1261
Berger, C.; Gacon, P. 1995: N-acylated derivatives of mixtures of amino acids derived from hydrolysates of cereal proteins and their applications. Official Gazette of the United States Patent and Trademark Office Patents 1179(3): 1749
Fahmy, M.A.H.; Harrison, C.R.; Lahm, G.P.; Stevenson, T.M. 1997: N-acylated pyrazolines. Official Gazette of the United States Patent and Trademark Office Patents 1194(1): 453
Fahmy, M.A.H.; Harrison, C.R.; Lahm, G.P.; Stevenson, T.M. 1996: N-acylated pyrazolines, compositions and use. Official Gazette of the United States Patent and Trademark Office Patents 1183(2): 863
Pecar, S.; Sollner, M.; Urleb, U.; Kikelj, D.; Marc, G.; Krbavcic, A.; Kotnik, V.; Wraber Herzog, B.; Simcic, S.; Ihan, A.; Klamfer, L.; Povsic, L.; Kopitar, Z.; Stalc, A. 1996: N-acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same. Official Gazette of the United States Patent and Trademark Office Patents 1186(1): 431
Honda, S.; Torii, K.; Arai, Y.; Kasai, M.; Kato, H.; IIda, T.; Takahashi, T.; Yokoo, Y.; Kamiya, T.; Tamaoki, T. 1995: N-acylglutamine derivatives and cosmetic compositions. Official Gazette of the United States Patent and Trademark Office Patents 1180(3): 1717
Merkler, D.J.; Asser, A.S.; Deblassio, J.L.; Gee, A.J.; Johnson, M.E.; Liang, H.; Merkler, K.A.; Chowdury, S.R.y 1997: N-acylglycines as substrates for peptidylglycine alpha-amidating enzyme. FASEB Journal 11(9): A1135
Gillum, M.P.; Zhang, D.; Zhang, X.-M.; Erion, D.M.; Jamison, R.A.; Choi, C.; Dong, J.; Shanabrough, M.; Duenas, H.R.; Frederick, D.W.; Hsiao, J.J.; Horvath, T.L.; Lo, C.M.; Tso, P.; Cline, G.W.; Shulman, G.I. 2008: N-acylphosphatidylethanolamine, a gut- derived circulating factor induced by fat ingestion, inhibits food intake. Cell 135(5): 813-824
Blochet, J.E.; Pezolet, M. 1993: N-acylphosphatidylethanolamines Effect of the chain length on the orientation of the N-acyl chain. Biophysical Journal 64(2 Part 2): A294
Ghyczy, M. 1996: N-acylphosphatidylethanolamines as anti-oxidants. Official Gazette of the United States Patent and Trademark Office Patents 1187(1): 446
Maccoss, M.; Mills, S.G. 1997: N-acylpiperidine tachykinin antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1196(2): 1160-1161
Capet, M.; Dubroeucq, M C.; Manfre, F. 1998: N-acylpyrrolidines and medicaments for the treatment or prevention of disorders linked to CKK and to gastrin. Official Gazette of the United States Patent and Trademark Office Patents 1206(2): 1394-1395
Morozov, I.S.; Klimova, N.V.; Lavrova, L.N.; Avdyunina, N.I.; Pyatin, B.M.; Troitskaya, V.S.; Bykov, N.P. 1998: N-adamantyl derivatives of aromatic amines Communication I Synthesis and neurotropic activity of N- anilines. Khimiko-Farmatsevticheskii Zhurnal 32(1): 3-6
Horishita, T.; Harris, R.A. 2008: N-Alcohols inhibit voltage-gated Na+ channels expressed in Xenopus oocytes. Journal of Pharmacology and Experimental Therapeutics 326(1): 270-277
Sandberg, R.E.; Adams, D.C.; Klopfenstein, T.J.; Grant, R.J. 1998: N-alkane as an internal marker for predicting digestibility of forages. Journal of Dairy Science 81(Suppl 1): 201
Bugalho, M.N.; Milne, J.A.; Mayes, R.W.; Rego, F.C. 1998: N-alkanes as markers for determining the diet of red deer grazing on Mediterranean type vegetation in southern Portugal. Revista de Biologia 16(1-4): 223
Li, P.K.; Chu, G.H.; Milano, S.; Kluth, L.; Rhodes, M. 1996: N-alkanoyl benzene as nonsteroidal estrone sulfatase inhibitors. Abstracts of Papers American Chemical Society 212(1-2): MEDI 47
Baccolini, G.; Gianelli, M. 1995: N-alkenyl-3,5-pyrazolidinediones from ketone hydrazones, PCl-3 and malonic acid. Tetrahedron 51(34): 9487-9492
Heinemann, U.; Krueger, B W.; Tiemann, R.; Dutzmann, S.; Stenzel, K. 1998: N-alkoxy-amidine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1208(3): 2381
Galema, S.A.; Engberts, J.B.F.N.; Van Doren, H.A. 1994: N-alkyl 1-thio-D-glycopyranosides The influence of stereochemistry on synthesis, purification, liquid crystalline behavior, solubility and aggregate morphology in water. Abstracts of Papers American Chemical Society 207(1-2): CARB 112
Berlin, K.D.; Garrison, G.L.; Sangiah, S.; Clarke, C.R.; Chen, C L.; Lazzara, R.; Scherlag, B.J.; Patterson, E.S.; Burrows, G.E. 1995: N-alkyl and N-acyl derivatives of 3,7-diazabicyclo- nonanes and selected salts thereof as multi-class antiarrhythmic agents. Official Gazette of the United States Patent and Trademark Office Patents 1180(3): 1824
Stark, H.; Kiec Kononowicz, K.; Reidermeister, S.; Moty, M.; Ligneau, X.; Garbarg, M.; Schwartz, J.C.; Schunack, W. 1996: N-alkyl carbamates as potent and selective histamine H3-receptor antagonists. European Journal of Pharmaceutical Sciences 4(Suppl ): S79
Steltenkamp, R.J. 1995: N-alkyl neotridecanamide insect repellents. Official Gazette of the United States Patent and Trademark Office Patents 1176(3): 1896
Tian, Y.M.; Griffiths, D.E. 1994: N-alkyl pyridiniums as inhibitors of complex 1. Biochemical Society Transactions 22(1): 71s
Ingall, A.H.; Cage, P.A.; Kindon, N.D. 1998: N-alkyl-2-substituted ATP analogues and administration to inhibit platelet aggregation. Official Gazette of the United States Patent and Trademark Office Patents 1207(4): 2946
Reizlein, K.; Engelhardt, U.; Horstmann, H O.; Singer, R J.; Wangermann, K.; Wirth, W. 1994: N-alkyl-lactams as crystallization inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1168(5): 3337
Parenti, M. 1996: N-alkyl-taurourodeoxycholic acids and their therapeutically active derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1184(3): 1739
Shan, J.H.; Nowak, G.; Izenwasser, S.; Witkin, J.M.; Newman, A.H.; (Usa), D.D.velop Group 1994: N-alkylaminobenzazepine analogs are highly selective dopamine-D-1 receptor antagonists. Abstracts of Papers American Chemical Society 208(1-2): MEDI 174
Moerlein, S.M.; Perlmutter, J.S.; Bockhorst, J.L.; Parkinson, D.; Welch, M.J. 1994: N-alkylated analogues of benperidol as dopaminergic D-2 receptor ligands. Journal of Labelled Compounds and Radiopharmaceuticals 35: 462-463
Goerlitzer, K.; Roth, A. 1995: N-alkylated and annulated pyridine derivatives from amino acids, Part 2 Oxazolo- and thiazolo pyridines. Pharmazie 50(11): 729-732
Yang, B.; Johnston, D.; Luedtke, R.R.; Mach, R.H. 1996: N-alkylated azabicyclononanes benzamides ad dopamine D-2/D-3 receptor ligands. Abstracts of Papers American Chemical Society 212(1-2): MEDI 148
Berkov, S.; Codina, C.; Viladomat, F.; Bastida, J. 2008: N-Alkylated galanthamine derivatives: Potent acetylcholinesterase inhibitors from Leucojum aestivum. Bioorganic and Medicinal Chemistry Letters 18(7): 2263-2266
Zhang, Y.; Tian, Z.; Kowalczuk, M.; Edwards, P.; Roeske, R.W. 1993: N-alkylation of pyridylalanine and pyridinecarboxylic acids and their use in synthesis of GnRH antagonists. Tetrahedron Letters 34(23): 3659-3662
Lin, J.Y.; Yang, M.H. 1994: N-alkylcarbamoyl derivatives of amino acids as chiral stationary phases for high-performance liquid chromatography I An example of enhancing enantioselectivity by deleting the non-enantioselective pi-pi interaction site on the chiral stationary phase. Journal of Chromatography A 684(1): 13-21
Edmonds Alt, X.; Martinez, S.; Proietto, V.; Van, B., D. 1995: N-alkylenepiperidino compounds, their enantiomers and pharmaceutical compositions. Official Gazette of the United States Patent and Trademark Office Patents 1174(1): 413-414
Levit, G.L.; Radina, L.B.; Krasnov, V.P. 1995: N-alkylnitrosocarbamoyl derivatives of amino acids Synthesis, properties and antitumor activity A review. Khimiko-Farmatsevticheskii Zhurnal 29(8): 10-17
Gaster, L.M.; Joiner, G.F.; Mulholland, K.R.; Wyman, P.A. 1998: N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1208(2): 1431-1432
Baudy, R.B.; Berta, S.C. 1995: N-alkynyl carboxamides as sertonergic agents. Official Gazette of the United States Patent and Trademark Office Patents 1178(3): 1681
Kessler, R.M.; Mason, N.S.; Ansari, M.S.; De Paulis, T.; Clanton, J.A.; Manning, R.G.; Holburn, G.; Forrester, J.W. 1994: N-allyl epidepride An extremely potent SPECT radioligand for the dopamine D2 receptor. Journal of Nuclear Medicine 35(5 Suppl): 199P
Steardo, L.; Monteleone, P.; d'Istria, M.; Serino, I.; Maj, M.; Cuomo, V. 1995: (+)-N-allylnormetazocine enhances N-acetyltransferase activity and melatonin synthesis: preliminary evidence for a functional role of sigma receptors in the rat pineal gland. Journal of Pharmacology and Experimental Therapeutics 275(2): 845-849
Bliss, P.W.; Calam, J. 1997: N-alpha methyl histamine in the gastric lumen stimulates acid secretion in human volunteers. Gastroenterology 112(4 Suppl): A72
Gordeev, M.F.; Patel, D.V.; Barker, P.L.; Gordon, E.M. 1994: N-alpha-Fmoc-4-phosphono -L-phenylalanine A new O-phosphotyrosine isosteric building block suitable for direct incorporation into peptides. Tetrahedron Letters 35(41): 7585-7588
D.B.ee, F.M.; Van Leeuwen, F.W.; Burbach, J.P.H. 1992: N-alpha-acetylated vasopressin in the rat pituitary gland and hypothalamus. Society for Neuroscience Abstracts 18(1-2): 1368
Curran, T.P.; Chandler, N.M.; Kennedy, R.J.; Keaney, M.T. 1996: N-alpha-benzoyl-cis-4-amino-L-proline A gamma-turn mimetic. Tetrahedron Letters 37(12): 1933-1936
Zhang, Z.; Yu, Y.; Liebeskind, L.S. 2008: N-amidation by copper-mediated cross-coupling of organostannanes or boronic acids with o-acetyl hydroxamic acids. Organic Letters 10(14): 3005-3008
Chen, X.; Yuan, J. 1997: N-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands. Official Gazette of the United States Patent and Trademark Office Patents 1205(5): 3909
Chen, X.; Wasley, J.W.F. 1997: N-aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands. Official Gazette of the United States Patent and Trademark Office Patents 1205(5): 3954
Masaki, M.; Miyake, N.; Tendo, A.; Takeda, H.; Ishida, M.; Shinozaki, H. 1996: N-aminoalkyl-substituted nitrogen-containing five membered heterocyclic compounds. Official Gazette of the United States Patent and Trademark Office Patents 1192(2): 1252
Yuan, J.; Chen, X. 1998: N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands. Official Gazette of the United States Patent and Trademark Office Patents 1206(3): 2230
Yuan, J.; Chen, X. 1997: N-aminoalkylfluorenecarboxamides A new class of dopamine receptor subtype specific ligands. Official Gazette of the United States Patent and Trademark Office Patents 1201(3): 2180
Njie, Y.Fatou.; Qiao, Z.; Xiao, Z.; Wang, W.; Song, Z-Hui. 2008: N-arachidonylethanolamide-induced increase in aqueous humor outflow facility. IOVS Investigative Ophthalmology and Visual Science 49(10): 4528-4534
Munk, S.A.; Harcourt, D.; Arasasingham, P.; Manlapaz, C.; Kharlamb, A.; Padillo, E.; Roberts, D.; Runde, E.; Williams, L.; Gil, D.; Burke, J.; Wheeler, L.; Garst, M. 1996: N-aryl aminoimidazoles Synthesis and evaluation as alpha-2 adrenergic agonists. Abstracts of Papers American Chemical Society 211(1-2): MEDI 22
Beck, J.P.; Bakthavatchalam, R.; Curry, M.A.; Fitzgerald, L.W.; Frietze, W.F.; Gilligan, P.J.; Huang, S.M.; Olson, R.E.; Robertson, D.W.; Shen, H.; Wilde, R.G.; Zaczek, R. 1998: N-aryl aminotriazolopyrimidines as corticotropin releasing hormone antagonists. Abstracts of Papers American Chemical Society 215(1-2): MEDI 140
Baasner, B.; Hagermann, H.; Heil, M.; Lieb, F.; Uhr, H.; Erdelen, C. 1998: N-aryl and N-alkylsulphonylaminals and pesticides. Official Gazette of the United States Patent and Trademark Office Patents 1208(2): 1436
Steltenkamp, R.J. 1995: N-aryl and N-cycloalkyl neoalkanamide insect repellents. Official Gazette of the United States Patent and Trademark Office Patents 1176(3): 1896
Chang, G.; Hamanaka, E.S.; Mccarthy, P.A.; Truong, T.V.; Walker, F.J. 1997: N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A Cholesterol acyl transferase. Official Gazette of the United States Patent and Trademark Office Patents 1201(2): 1306-1307
Beard, R.L.; Teng, M.; Colon, D.F.; Duong, T.T.; Chandraratna, R.A. 1998: N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity. Official Gazette of the United States Patent and Trademark Office Patents 1209(2): 1491
Van, H., J.C.; Kleschick, W.A.; Arndt, K.E.; Costales, M.J.; Ehr, R.J.; Bradley, K.B.; Reifschneider, W.; Benko, Z.; Ash, M.L.; Jachetta, J.J. 1997: N-aryl triazolo pyridine-2-sulfonamide herbicides. Official Gazette of the United States Patent and Trademark Office Patents 1205(4): 3105
Jacobson, R.M. 1998: N-aryl-3-aryl-4-substituted-4,5-dihydro-1H-pyrazole-1-carboxamides and methods of their production. Official Gazette of the United States Patent and Trademark Office Patents 1213(4): 3718
Trotto, S.; Furch, J.A.IIi; Kuhn, D.G.; Hunt, D.A. 1996: N-aryl-and N-heteroarylhydrazones of substituted thioacids and thes-oxides thereof as insecticidal and acaricidal agents. Official Gazette of the United States Patent and Trademark Office Patents 1190(3): 2081-2082
Fischer, R.; Jensen Korte, U.; Kunisch, F.; Marhold, A.; Ooms, P.; Schallner, O.; Santel, H J.; Schmidt, R.R.; Krauskopf, B.; Strang, H. 1996: N-aryl-substituted nitrogen-containing heterocycles intermediates and their use as herbicides and plant growth regulators. Official Gazette of the United States Patent and Trademark Office Patents 1190(2): 1241
Van, H., J.C.; Kleschick, W.A.; Arndt, K.E.; Costales, M.J.; Ehr, R.J.; Bradley, K.B.; Reifschneider, W.; Benko, Z.; Jachetta, J.J. 1996: N-aryl1,2,4triazolo1,5-Apyridine-2-sulfonamide herbicides. Official Gazette of the United States Patent and Trademark Office Patents 1192(1): 438-439
Lind, P.T.; Noreen, R.; Morin, J.M.; Ternansky, R.J. 1998: N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection. Official Gazette of the United States Patent and Trademark Office Patents 1217(3): 2605-2606
Park, N S.; Jung, Y S.; Seong, C M.; Lee, J C.; Choi, J I.; Choi, S W.; Choi, Y J.; Lee, K S. 1997: N-arylalkylphenylacetamide derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1202(4): 3123
Takematsu, T.; Kume, T.; Yamaoka, S.; Komata, T.; Suzuki, K.; Ikeda, Y.; Kawamura, M.; Koda, Y.; Mori, K. 1996: N-aryloxyacyl-N-phenyltetrahydrophthalamic acid derivatives, methods of producing same, and herbicides containing same as effective components. Official Gazette of the United States Patent and Trademark Office Patents 1182(1): 466
Pfister, J.R.; Clarke, D.E. 1995: N-aryloxyalkyl tryptamine alpha-1-adrenergic receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1176(4): 2637
James, D.R.; Felix, R.A. 1994: N-benzotriazoles. Official Gazette of the United States Patent and Trademark Office Patents 1168(5): 3324-3325
Matyus, P.; Zara, E.; Farkas, L.; Papp, A.; Simay, A.; Toldy, L.; Andrasi, F.; Goldschmidt, K.; Hodula, E.; Mathe, I.; Sutka, K.; Fittler, Z.; Vitkoczi, V.; Sebestyen, L.; Sziraki, I.; Rusz, M.; Gal, E. 1998: N-benzoyl amino acid derivatives pharmaceutical compositions containing them and process for preparing same. Official Gazette of the United States Patent and Trademark Office Patents 1206(1): 493-494
Srivastava, R.P.; Zjawiony, J.K.; Peterson, J.R.; Mcchesney, J.D. 1994: N-benzoyl- -phenylisoserine methyl ester A facile and convenient synthesis and resolution by entrainment. Abstracts of Papers American Chemical Society 207(1-2): MEDI 84
Matyus, P.; Zara, E.; Farkas, L.; Papp, A.; Simay, A.; Toldy, L.; Andrasi, F.; Goldschmidt, K.; Hodula, E.; Mathe, I.; Sutka, K.; Fittler, Z.; Vitkoczi, V.; Sebestyen, L.; Sziraki, I.; Rusz, M.; Gal, E. 1998: N-benzoylamino acid derivatives, pharmaceutical compositions containing them and process of preparing same. Official Gazette of the United States Patent and Trademark Office Patents 1217(5): 4209
Foguet, R.; Gubert, S.; Sacristan, A.; Ortiz, J.A. 1997: N-benzoylmethyl-piperdines. Official Gazette of the United States Patent and Trademark Office Patents 1202(2): 1374
Lau, C.K.; Black, C.; Guay, D.; Gauthier, J Y.; Leblanc, Y.; Roy, P.; Ducharme, Y.; Hamel, P. 1997: N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1199(3): 1939-1940
Huang, Y.nsheng; Whirrett, Brian; Childers, Steven, R.; Mach, Robert, H. 1997: N-benzyl-4-aminopiperidine phenylacetamide analogues as potent sigma-1/sigma-2 receptor ligands. Abstracts of Papers American Chemical Society 213(1-3): MEDI 55
Lau, C.K.; Black, C.; Guay, D.; Gauthier, J.Y.; Leblanc, Y.; Roy, P.; Ducharme, Y.; Hamel, P. 1997: N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1195(3): 1956-1957
Korlipara, V.L.; Takemori, A.E.; Portoghese, P.S. 1994: N-benzylnaltrindoles as long-acting delta-opioid receptor antagonists. Journal of Medicinal Chemistry 37(12): 1882-1885
Amadori, D.; Marangolo, M.; Pacini, P.; Ravaioli, A.; Rossi, A.; Gambi, A.; Catalano, G.; Perrone, D.; Giunchi, D.C.; Becciolini, A.; Volpi, A.; Nanni, O. 1996: N-breast cancer patients Prospective use of tumour proliferative activity for adjuvant therapy. International Journal of Biological Markers 11(2): 132-133
Ebeid, M.Y.; Moussa, B.A.; A Malek, A.; Ashour, F.M. 1998: N-bromosuccinimide as an analytical reagent for the determination of some antihypertensive agents. Egyptian Journal of Pharmaceutical Sciences 38(1-3): 171-182
Cettour, P.; Descotes, G.; Praly, J.P.erre 1995: N-bromosuccinimide-mediated transformations of acetylated 1,5-anhydro-1-C-phenyl-D-hexitols. Journal of Carbohydrate Chemistry 14(3): 445-449
Baek, R.C.; Kasperzyk, J.L.; Platt, F.M.; Seyfried, T.N. 2008: N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice. Neurochemistry International 52(6): 1125-1133
Pollock, S.; Dwek, R.A.; Burton, D.R.; Zitzmann, N. 2008: N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery. Aids 22(15): 1961-1969
Fukuzawa, T.; Obika, M. 1994: N-cadherin expression is lost when neural crest cells differentiate into melanophores in Xenopus laevis. Pigment Cell Research 7(5): 371
Haug, J.S.; He, X.C.; Grindley, J.C.; Wunderlich, J.P.; Gaudenz, K.; Ross, J.T.; Paulson, A.; Wagner, K.P.; Xie, Y.; Zhu, R.; Yin, T.; Perry, J.M.; Hembree, M.J.; Redenbaugh, E.P.; Radice, G.L.; Seidel, C.; Li, L. 2008: N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells. Cell Stem Cell 2(4): 367-379
Nieman, M.T.; Ethier, S.P.; Johnson, K.R.; Wheelock, M.J. 1998: N-cadherin expression promotes invasive phenotype in breast carcinoma cell lines. Proceedings of the American Association for Cancer Research 39: 400
Li, J.; Levin, M.D.; Xiong, Y.; Petrenko, N.; Patel, V.V.; Radice, G.L. 2008: N-cadherin haploinsufficiency affects cardiac gap junctions and arrhythmic susceptibility. Journal of Molecular and Cellular Cardiology 44(3): 597-606
Beesley, P.W.; Mummery, R.; Tibaldi, J. 1994: N-cadherin is enriched in rat forebrain post synaptic density preparations. Society for Neuroscience Abstracts 20(1-2): 865
Ferreira Cornwell, M.C.; Grunwald, G.B.; Menko, A.S. 1995: N-cadherin plays a role in the differentiation of lens epithelial cells. Molecular Biology of the Cell 6(Suppl ): 171A
Hazan, R.B.; Kang, L.; Whooley, B.P.; Borgen, P.I. 1996: N-cadherin promotes adhesion between invasive breast cancer cell lines and the stroma. Molecular Biology of the Cell 7(Suppl ): 421A
Redfield, A.R.; Knudsen, K.A. 1996: N-cadherin promotes the differentiation of BHK cells into skeletal muscle. Molecular Biology of the Cell 7(Suppl ): 423A
George Weinstein, M.; Gerhart, J.; Reed, R.; Mattiacci, M.; Simak, E.; Steinberg, A.; Dawkins, S.; Knudsen, K. 1996: N-cadherin promotes the differentiation of chick embryo epiblast cells into skeletal muscle. Molecular Biology of the Cell 7(Suppl ): 40A
Perron, J.C.; Bixby, J.L. 1998: N-cadherin- and laminin-induced neurite outgrowth requires ERK signaling. Society for Neuroscience Abstracts 24(1-2): 1281
Hertig, C.; Eppenberger, M.; Butz, S.; Kemler, R.; Eppenberger, H.M. 1995: N-cadherin-catenin mediated cell contact in adult rat cardiomyocytes Truncated N-cadherin mutant impair cell contact and communication. Experientia 51(ABSTR ): A62
Linask, K.K.; Qui, Y.; Lee, H.Y.; Nagele, R.G. 1998: N-cadherin/beta-catenin interactions with microfilament bundles during neural tube formation in the chick. Molecular Biology of the Cell 9(Suppl ): 47A
Linask, K.K.; Yan, A.C.; Knudsen, K.A. 1996: N-cadherin/catenin complex involvement in early avian heart development. Molecular Biology of the Cell 7(Suppl ): 485A
Leblanc, L.; Borgford, T. 1995: N-cap mutants in the regulatory domain of chicken troponin-C. Biophysical Journal 68(2 Part 2): A58
Kim, W.H.; Lee, J.H.; Cho, H.S.; Kim, S.D.; Paik, W.K.; Kim, M.W. 1998: N-carbamoyl-L-glutamate plus L-arginine can protect ammonia intoxication in rats with cirrhosis. Hepatology 28(4 Part 2): 668A
Rana, A.; Siddiqui, N.; Khan, S.A.; Ehtaishamul Haque, S.; Bhat, M.A. 2008: N-{[(6-substituted-1,3-benzothiazole-2-yl)amino]carbonothioyl}-2/4-substituted benzamides: synthesis and pharmacological evaluation. European Journal of Medicinal Chemistry 43(5): 1114-1122
Hussain, A.A.; Tashtoush, B.; Dittert, L.W. 1998: N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters as novel safe agents for water disinfection. Official Gazette of the United States Patent and Trademark Office Patents 1210(3): 2631
Tashtoush, B.; Kao, H.D.; Hussain, A.A. 1995: N-chloro-N-methylglucamine A potentially useful water disinfectant I Chemistry. Pharmaceutical Research (New York) 12(9 Suppl): S323
Cho, E.H.; Chung, S.G.; Lee, K.H.; Park, S.K. 1998: N-cinnamoyl-2-methyl-5-methoxy-3-indoleacetic acid ester, and pharmaceutical preparation containing the same. Official Gazette of the United States Patent and Trademark Office Patents 1210(1): 524
Shah, J.H.; Izenwasser, S.; Witkin, J.M.; Geter Douglass, B.; Newman, A.H. 1995: N-cinnamyl benzazepine analogs are potent and selective dopamine-D-1 receptor ligands. Abstracts of Papers American Chemical Society 209(1-2): MEDI 85
Furuta, H.; Asano, T.; Ogawa, T. 1994: N-confused porphyrin A new isomer of tetraphenylporphyrin. Journal of the American Chemical Society 116(2): 767-768
Bramm, E.; Petersen, H.J. 1996: N-cyano-N-pyridylguanidines as serotonin antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1191(2): 1121
Andree, R.; Drewes, M W.; Marhold, A.; Santel, H J.; Dollinger, M. 1997: N-cyanoaryl-nitrogen heterocycles. Official Gazette of the United States Patent and Trademark Office Patents 1194(2): 1215-1216
Haase, J.; Kuhn, M. 1998: N-cyanomethylated chitosans and hydrolysates thereof. Official Gazette of the United States Patent and Trademark Office Patents 1209(3): 2353
Hsu, K H.L.; Teller, D.M.; Davis, A.R.; Lubeck, M.D.; Munson, H.R.Jr; Jagdmann, G.E.; Uwaydah, I.M. 1996: N-cyanomidine derivatives as anti-influenza agents. Official Gazette of the United States Patent and Trademark Office Patents 1186(3): 2029
Evans, C.A.; Miller, E.K.; Friedland, A.J. 1996: N-cycling rates in high elevation spruce fir forests The effects of community heterogeneity. Bulletin of the Ecological Society of America 77(3 Suppl Part 2): 132
Eicken, K.; Ammermann, E.; Lorenz, G. 1995: N-cyclohex yl-pyridine carboxamides and compositions containing them for controlling fungal pests. Official Gazette of the United States Patent and Trademark Office Patents 1174(3): 1923
Oturai, P.S.; Rolin, B.; Jensen, T.; Kofoed Enevoldsen, A. 1996: N-deacetylase mRNA expression in diabetic rats. Diabetologia 39(Suppl 1): A309
Pogell, B.M. 1993: N-dealkylation and complete degradation of atrazine by microorganisms. Baltz, R H, Hegeman, G D, Skatrud, P P Industrial microorganisms: Basic and applied molecular genetics: 284
Wilkins, L.H.; Pauly, J.R.; Crooks, P.A.; Dwoskin, L.P. 1997: N-decylnicotinium iodide inhibits nicotine-evoked 86Rubidium+ efflux from rat striatal synaptosomes. Society for Neuroscience Abstracts 23(1-2): 1198
Schmider, J.; Greenblatt, D.J.; Von Moltke, L.L.; Shader, R.I. 1995: N-demethylation of amitriptyline in vitro Role of CYP3A isoforms. Clinical Pharmacology and Therapeutics 57(2): 193
Christ, W.; Hecker, W.; Christ, H.; Kemmler, H. 1994: N-demethylation of chlorpromazine , imipramine , tilidine and diazepam by microsomes of small intestine from guinea pig. Naunyn-Schmiedeberg's Archives of Pharmacology 349(Suppl): R4
ChenTing; DaiYiJun; DingJuanFang; YuanSheng; NiJuePing 2008: N-demethylation of neonicotinoid insecticide acetamiprid by bacterium Stenotrophomonas maltophilia CGMCC 11788. Biodegradation: 5, 651-658. Ef
Sinniger, V.; Chovet, M.; Lamy, C.; Fournet, J.; Feuerstein, C.; Bonaz, B. 1998: N-desmethyl-trimebutine prevents visceral pain-induced c-Fos expression in the rat spinal cord. Society for Neuroscience Abstracts 24(1-2): 381
Bergijk, E.C.; Van Alderwegen, I.E.; Sutmuller, M.; Baelde, J.J.; And, E.D.H.er; Bruijn, J.A. 1995: N-desulfated heparinoids prevent the development of glomerulosclerosis in experimental lupus nephritis. Journal of the American Society of Nephrology 6(3): 892
Weber, B.; Riess, O.; Daneshvar, H.; Graham, R.; Hayden, M.R. 1993: N-dinucleotide repeat at the PDEB locus in 4p163. Human Molecular Genetics 2(6): 827
Riess, O.; Weber, B.; Hayden, M.R. 1992: N-dinucleotide repeat polymorphism at the locus for the alpha2C adrenergic receptor on 4p16. Human Molecular Genetics 1(6): 452
Katz, D.H.; Pope, L.E.; Marcelletti, J.F.; Khalil, M.H.; Katz, L.R. 1994: N-docosanol A new broad spectrum anti-viral drug. Clinical Research 42(2): 300A
Bunke, A.; Jira, T.; Beyrich, T. 1997: N-dodecyl-N-methylephedrinium bromide as chiral selector in capillary electrophoresis. Pharmazie 52(10): 762-764
Badoud, R.; Fay, L. 1995: N-epsilon-carboxymethyllysine and N-carboxymethyl amino acids as indicators of the early Maillard reaction. Abstracts of Papers American Chemical Society 210(1-2): AGFD 102
Puri, R.N.; Colman, R.W. 1996: N-ethyl-5-phenylisooxazolium-3-sulfonate inhibits ADP-induced platelet responses by inhibiting binding of ADP to aggregin, an ADP receptor. FASEB Journal 10(6): A1099
Goh, L.B.; Tu, Y.H.; Lee, C.W. 1994: N-ethylmaleimide A possible covalent label for NBMPR-insensitive nucleoside transport of murine myeloma cells. Proceedings of the American Association for Cancer Research 35: 576
Bellingham, M.C.; Walmsley, B. 1998: N-ethylmaleimide alters evoked quantal transmitter release asynchrony and enhances spontaneous quantal release frequency. Society for Neuroscience Abstracts 24(1-2): 1315
Phelan, K.D.; Mahler, H.R. 1996: N-ethylmaleimide alters the intrinsic membrane properties and inhibitory synaptic potentials of neurons in a rat septal slice preparation. Society for Neuroscience Abstracts 22(1-3): 811
Alger, B.E.; Pitler, T.A.; Wagner, J.J. 1995: N-ethylmaleimide blocks depolarization-induced suppression of inhibition in rat hippocampal pyramidal cells. Society for Neuroscience Abstracts 21(1-3): 1093
Wenge, B.; Bönisch, H. 2008: N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter. Naunyn-Schmiedeberg's Archives of Pharmacology 377(3): 255-265
Alexander, S.P.H.; Curtis, A.R.; Kendall, D.A. 1994: N-ethylmaleimide effects on adenosine receptor function in the guinea-pig cerebral cortex. British Journal of Pharmacology 111(Proceedings Suppl JAN ): 258P
Lauf, P.K.; Moezzi, R.; Adragna, N.C. 1994: N-ethylmaleimide treatment of low K sheep red blood cells at different temperatures reveals role of thiols and Mg for activation and inactivation of K-Cl cotransport. Biophysical Journal 66(2 Part 2): A32
Subramaniam, V.N.; Loh, E.; Hong, W. 1997: N-ethylmaleimide-sensitive factor and alpha-soluble NSF attachment proteins mediate dissociation of GS28-syntaxin 5 Golgi SNAP receptors complex. Journal of Biological Chemistry 272(41): 25441-25444
Katano, T.; Furue, H.; Okuda-Ashitaka, E.; Tagaya, M.; Watanabe, M.; Yoshimura, M.; Ito, S. 2008: N-ethylmaleimide-sensitive fusion protein (NSF) is involved in central sensitization in the spinal cord through GluR2 subunit composition switch after inflammation. European Journal of Neuroscience 27(12): 3161-3170
Angelico, M.; Mangiameli, A.; Nistri, A.; Sofia, M.; Di Martino, M.; Maina, M.; Baiocchi, L.; Blasi, A. 1994: N-ethyltauroursodeoxycholic acid, a novel bile salt analogue resistant to bacterial deconjugation Effect of chronic gastric feeding in the rat. Gastroenterology 106(4 Suppl): A860
Sulieman,S.; Fischinger,S.; Schulze,J. 2008: N-feedback regulation of N2 fixation in Medicago truncatula under P-deficiency. General And Applied Plant Physiology: 1 2, 33-54
Ying, W.; Desmarteau, D.D.; Gotoh, Y. 1996: N-fluoro-bis sulfonyl Imide Electrophilic fluorination of imines and some methyl-substituted pyridines. Tetrahedron 52(1): 15-22
Prossnitz, E.R. 1997: N-formyl peptide receptor phosphorylation is required for internalization and desensitization but not chemotaxis. Molecular Biology of the Cell 8(Suppl ): 383A
Baker, C.S.; Goijburg, D.L.; Phillips, A.T. 1997: N-formylglutamate amidohydrolase from Pseudomonas putida Sequence and properties. Abstracts of the General Meeting of the American Society for Microbiology 97: 370
Prossnitz, E.R.; Schreiber, R.E.; Bokoch, G.M.; Cochrane, C.G.; Ye, R.D. 1992: N-formylpeptide receptor domains involved in receptor-G protein interactions. Journal of Leukocyte Biology 1992(Suppl 3): 50
Hodson, H.F. 1998: N-g-monomethyl-L-arginine hydrochloride derivatives and their use in the treatment of septic shock. Official Gazette of the United States Patent and Trademark Office Patents 1211(3): 2985
Schupke, H.; Bauer, C.; Mcneilly, P.J.; Hempel, R.; Strong, J.; Kupferberg, H.J.; Kronbach, T. 1996: N-glucuronidation as a major metabolic pathway of the new anticonvulsant D-23129 in rats, dogs and man. Naunyn-Schmiedeberg's Archives of Pharmacology 354(4 Suppl 1: R43
Babu, S.; Lakshimi, V.; Kane, R.; Hsu, F.; Zenser, T.; Davis, B. 1993: N-glucuronidation of benzidine by human liver. Proceedings of the American Association for Cancer Research 34: 163
Mackiewicz, A.; Khan, M.A.; Calabrese, L.; Espinoza, L.R. 1992: N-glycan microheterogeneity of alpha-1-acid glycoprotein in HIV infected patients with and without arthritis. Arthritis and Rheumatism 35(9 Suppl): S86
Takahashi, M.; Yokoe, S.; Asahi, M.; Lee, S.H.; Li, W.; Osumi, D.; Miyoshi, E.; Taniguchi, N. 2008: N-glycan of ErbB family plays a crucial role in dimer formation and tumor promotion. Biochimica et Biophysica Acta 1780(3): 520-524
Ruddock, L.W.; Molinari, M. 2006: N-glycan processing in ER quality control. Journal of Cell Science 119(Part 21): 4373-4380
Xie, W.; Gender, S.J. 1996: N-glycans direct the apical expression of the epithelial mucin MUC1 in cells. Molecular Biology of the Cell 7(Suppl ): 77A
Lige, B.; Van Huystee, R.B. 1997: N-glycosylated analysis of the cationic peanut peroxidase expressed in transgenic tobacco plants. Plant Physiology (Rockville) 114(3 Suppl): 299
Lerouge, P.; Fitchette Laine, A.C.; Cabanes, M.; Ma, J.; Faye, L. 1996: N-glycosylation analysis of a mouse monoclonal antibody expressed in transgenic tobacco plants. Plant Physiology (Rockville) 111(2 Suppl): 168
He, Y.; Ramsay, A.J.; Hunt, M.L.; Whitbread, A.K.; Myers, S.A.; Hooper, J.D. 2008: N-glycosylation analysis of the human Tweety family of putative chloride ion channels supports a penta-spanning membrane arrangement: impact of N-glycosylation on cellular processing of Tweety homologue 2 (TTYH2). Biochemical Journal 412(1): 45-55
Martinez, J.A.; Banerjee, D.K. 1998: N-glycosylation inhibition on endothelial cell proliferation and viability. FASEB Journal 12(8): A1350
Maciewicz, R.A.; Van Der Stappen, J.W.J.; Paraskeva, C. 1994: N-glycosylation of cysteine proteinase inhibitors A possible control mechanism for the determination of malignant potential. Journal of Cellular Biochemistry Suppl 1994(18D): 145
Gehle, V.M.; Sumikawa, K. 1992: N-glycosylation of nicotinic acetylcholine receptor subunits is required for efficient intracellular transport of assembled receptors. Society for Neuroscience Abstracts 18(1-2): 437
Kedzierski, W.; Bok, D.; Travis, G.H. 1997: N-glycosylation of rds/peripherin Role in protein processing and the formation of photoreceptor outer segments. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S1165
Huang, L.; Fu, D.; Spellman, M.W.; Van Halbeek, H. 1992: N-glycosylation site mapping of recombinant HIV-1 envelope glycoprotein-120 expressed in CHO cells. Glycobiology 2(5): 473
Schwalbe, R.A.; Wang, Z.; Brown, A.M. 1996: N-glycosylation studies of ROMK1 reveal unexpected extracellular regions in the pore-forming segment. Biophysical Journal 70(2 Part 2): A309
Schwalbe, R.A.; Bianchi, L.; Brown, A.M. 1997: N-glycosylation tags and K+ selectivity in ROMK1. Biophysical Journal 72(2 Part 2): A254
Wu, Y.Q.; Wilkinson, D.; Soni, R.; Scott, C.; Ross, D.T.; Guo, H.; Howorth, P.; Chen, Y.; Valentine, H.; Liang, S.; Spicer, D.; Steiner, J.; Hamilton, G. 1998: N-glyoxyl prolyl and pipecolyl amide FKBP12 ligands Potent neurotrophic agents in an animal model of Parkinsons disease. Abstracts of Papers American Chemical Society 216(1-3): MEDI 103
Schueytze, R.; Kehne, H.; Bauer, K.; Bieringer, H. 1998: N-heteroartyl-N- ureas, processes for their preparation, and their use as herbicides and plant growth regulators. Official Gazette of the United States Patent and Trademark Office Patents 1217(2): 1669-1670
Strupczewski, J.T.; Glamkowski, E.J. 1996: N-heteroaryl-1-pyrrolidinylalkyl-2-benoxazolinones and related compounds and their therapeutic utility. Official Gazette of the United States Patent and Trademark Office Patents 1193(1): 463
Haaf, K.; Kehne, H.; Bauer, K.; Bieringer, H. 1998: N-heteroaryl-N- ureas, processes for their preparation, and their use as herbicides and plant growth regulators. Official Gazette of the United States Patent and Trademark Office Patents 1207(1): 435-436
Agback, H.; Ahrgren, L.; Berglindh, T.; Haraldsson, M.; Smedegard, G.; Olsson, L I. 1996: N-heterocyclic substituted salicylic acids. Official Gazette of the United States Patent and Trademark Office Patents 1190(3): 2070
Phillips, P.J.; Ballard, P.G.; Bradbury, R.H.; James, R. 1997: N-heterocyclic sulfonamides having endothelin receptor activity. Official Gazette of the United States Patent and Trademark Office Patents 1202(3): 2233-2234
Baudy, R.B.; Berta, S.C. 1997: N-heterocycloalkyl carboxamides as serotonergic agents. Official Gazette of the United States Patent and Trademark Office Patents 1195(2): 1206
Easaw, P.E.S. 1997: N-hexane neuropathy as an occupational disease A clinical and neurophysiological study of four cases. Journal of the Neurological Sciences 150(Suppl ): S64
Bhattarai, S.R.; Kc, R.B.; Kim, S.Y.; Sharma, M.; Khil, M.S.; Hwang, P.H.; Chung, G.H.; Kim, H.Y. 2008: N-hexanoyl chitosan stabilized magnetic nanoparticles: Implication for cellular labeling and magnetic resonance imaging. Journal of Nanobiotechnology 6: 1
Pushkareva, M.Y.; Janoff, A.S. 1996: N-hexanoyl- and N-hexyl sphingosine differentially effect mitochondrial membrane potential changes leading to apoptosis. Molecular Biology of the Cell 7(Suppl ): 348A
Theodorakis, E.A.; Wilcoxen, K.M. 1996: N-hydroxy-2-thiopyridone and derivatives as generators of oxygen radicals Design of new DNA-photocleaving reagents. Abstracts of Papers American Chemical Society 211(1-2): ORGN 135
Allen, R.C.; Helsley, G.C.; Hamer, R.R.; Freed, B.S.; White, J.L.; Martin, L.L. 1998: N-hydroxy-dibenz oxepinalkylamines, N-hydroxy-dibenz oxepinalkanoic acid amides and related heterocyclic analogues. Official Gazette of the United States Patent and Trademark Office Patents 121(4): 4026
Harsanyi, K.; Gizur, T.; Agai Csongor, E.; Kallai Sohonyai, A.; Kapolnas Pap, M.; Csizer, E.; Hegedus, B.; Szporny, L.; Kiss, B.; Karpati, E.; Palosi, E.; Szombathelyi, Z.; Sarkadi, A.; Gere, A.; Bodo, M.; Csomor, K.; Laszy, J.; Szentirmai, Z.; Lapis, E.; Szabo, S. 1996: N-hydroxyalkyl-substituted 1,2,3,6-tetrahydro-pyridine and piperidine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1193(5): 3581
Ohkanda, J.; Katoh, A. 1995: N-hydroxyamide-containing heterocycles Part 5 Synthesis of novel hexadentate ligands composed of N-hydroxy-2 -pyrazinone, aliphatic diamine, and 1,1,1-tris ethane, and properties of their ferric complexes. Tetrahedron 51(47): 12995-13002
Watanabe, M.; Igarashi, T.; Kaminuma, T.; Sofuni, T.; Nohmi, T. 1994: N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium: proposal for a common catalytic mechanism of arylamine acetyltransferase enzymes. Environmental Health Perspectives 102(Suppl 6): 83-89
Landi, M.T.; Bertazzi, P.A.; Caporaso, N.E.; Kadlubar, F.F.; Tannembaum, S.; Skipper, P.; Vineis, P. 1995: N-hydroxylation and hemoglobin adducts. Proceedings of the American Association for Cancer Research 36: 283
Ando, K.; Ikeda, T. 1995: N-hydroxyurea derivatives which inhibit lipoxygenase. Official Gazette of the United States Patent and Trademark Office Patents 1170(4): 2504-2505
Malamas, M.S.; Nelson, J.A. 1995: N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein. Official Gazette of the United States Patent and Trademark Office Patents 1179(3): 1830
Ando, A.; Stevens, R.W. 1998: N-hydroxyureas as antiinflammatory agents. Official Gazette of the United States Patent and Trademark Office Patents 1214(5): 5339
Nishiuchi, Y.ji; Nishio, Hideki; Inui, Tatsuya; Kimura, Terutoshi; Sakakibara, Shumpei 1996: N-in-cyclohexyloxycarbonyl group as a new protecting group for tryptophan. Tetrahedron Letters 37(42): 7529-7532
Katerinopoulos, H.E.; Tagmatarchis, N.; Thermos, K. 1997: N-iodopropenyl-octahydrobenzo - and - quinoline analogs with adrenergic and dopaminergic activity. Abstracts of Papers American Chemical Society 214(1-2): MEDI 21
Tokaji, Z.; Der, A. 1996: N-like intermediate of the photocycle of acid purple form of bacteriorhodopsin. Progress in Biophysics and Molecular Biology 65(Suppl 1): 165
Shakin Eshleman, S.; Kasturi, L.; Clute, J. 1996: N-linked core-glycosylation efficiency is influenced by the X and hydroxy amino acids in ASN-X-SER/THR sequons. FASEB Journal 10(6): A1369
Garrity, R.; Minassian, A.; Rimmelzwaan, G.; Tsai, W.P.; Dunlop, N.; Conley, S.; Goudsmit, J.; Nara, P. 1994: N-linked epitope masking results in shift in neutralizing response away from V3 to V1. AIDS Research and Human Retroviruses 10(Suppl 3): S134
Trimble, R.B.; Verostek, M. 1993: N-linked glycan modeling in yeast Control through sugar transferase substrate specificity or by the cellular subcompartmentation of processing enzymes?. Glycobiology 3(5): 515
Burda, Patricie; Te Heesen, Stephen; Aebi, Markus 1996: N-linked glycosylation ALG9 and ALG10, two new loci involved in the biosynthesis of dolichol-linked oligosaccharides in Saccharomyces cerevisiae. Molecular Biology of the Cell 7(Suppl ): 132A
Chakraborty, A.K.; Sodi, S.A.; Orlow, S.J.; Rosemblat, S.; Keh Yen, A.; Bolognia, J.; Rachkovsky, M.L.; Pawelek, J. 1998: N-linked glycosylation as a regulator of phenotypic expression in melanoma x macrophage fusion hybrids. Proceedings of the American Association for Cancer Research 39: 496
Zufferey, R.; Reiss, G.; Burda, P.; Te Heesen, S.; Aebi, M. 1995: N-linked glycosylation in yeast The essential gene SLW1 is required for the transfer of the core oligosaccharide to asparagine residues in vivo. Experientia 51(ABSTR ): A74
Karpa, K.D.; Bergson, C.; Levenson, R. 1998: N-linked glycosylation is essential for plasma membrane localization of human D5 dopamine. Society for Neuroscience Abstracts 24(1-2): 1360
Vukmirica, J.; Nishimaki Mogami, T.; Mcleod, R.S.; Yao, Z. 1998: N-linked glycosylation is important for posttranslational stability and efficient secretion of apo-B. Molecular Biology of the Cell 9(Suppl ): 346A
Davis, D.P.; Liu, X.; Segaloff, D.L. 1995: N-linked glycosylation is required for functional maturation of the FSH and the LH/CG receptors. FASEB Journal 9(6): A1249
Hair, G.A.; Schmeizl, M.; Distasio, D.; Zeff, R.; Rickles, F.R. 1994: N-linked glycosylation is required for membrane expression of cellular tissue factor. Clinical Research 42(2): 183A
Kolhekar, A.S.; Quon, A.S.W.; Berard, C.A.; Mains, R.E.; Eipper, B.A. 1997: N-linked glycosylation occurs posttranslationally during the biosynthesis of a secretory granule enzyme. Molecular Biology of the Cell 8(Suppl ): 310A
Aebi, M.; Te Heesen, S.; Stagljar, I.; Zufferey, R.; Reiss, G.; Burda, P. 1995: N-linked glycosylation of proteins in the endoplasmic reticulum of Saccharomyces cerevisiae. Experientia 51(ABSTR ): A51
Khan, M.W.; Musgrave, S.C.; Jenkins, N. 1995: N-linked glycosylation of tissue plasminogen activator in Namalwa cells. Biochemical Society Transactions 23(1): 99s
Martayan, A.; Sibilio, L.; Setini, A.; Lo Monaco, E.; Tremante, E.; Fruci, D.; Colonna, M.; Giacomini, P. 2008: N-linked glycosylation selectively regulates the generic folding of HLA-Cw1. Journal of Biological Chemistry 283(24): 16469-16476
Yang, B.; Hoe, M.H.; Hunt, R.C. 1993: N-linked oligosaccharide at ASN727 of human transferrin receptor is required for exiting the endoplasmic reticulum when disulphide bridges of the receptor are interrupted by dithreitol. Molecular Biology of the Cell 4(Suppl ): 87A
Hounsell, E.F.; Davies, M.J.; Smith, K.D. 1996: N-linked oligosaccharide profiling by HPAEC-PAD. Walker, J M The protein protocols handbook 661-662
Hounsell, E.F.; Davies, M.J.; Smith, K.D. 1996: N-linked oligosaccharide profiling by HPLC on porous graphitized carbon. Walker, J M The protein protocols handbook 659-660
Bernardo, R.R.; Palatnik, D.S.usa, C.B.; Parente, J.P. 1997: N-linked oligosaccharide structures of the FML antigen of Leishmania donovani. Memorias do Instituto Oswaldo Cruz 92(Suppl 1): 146
Bjorklund, J.E.M.; Karlsson, T.; Magnusson, C.G.M. 1998: N-linked oligosaccharides influence the epitope expression of human myeloma IgE. Allergy 53(Suppl 43): 14
Steltenkamp, R.J. 1995: N-lower alkyl neoalkanamide insect repellents. Official Gazette of the United States Patent and Trademark Office Patents 1171(3): 1805
Zavanella,M.; Barbanti,L.; Venturi,G. 2008: N-management in beet with Nib software. Informatore Agrario: 44, 36-39
Fournie Zaluski, M C.; Roques, B P. 1997: N-mercaptoacyl compounds and S-lipophiic aliphatic carbonyl derivatives thereof as antihypertensives. Official Gazette of the United States Patent and Trademark Office Patents 1194(1): 495
Bidlack, J.M.; Kaplan, R.A.; Sebastian, A.; Seyed Mozaffari, A.; Hutchinson, I.; Archer, S. 1995: N-methyl and N-cyclopropylmethyl-14-alpha,14beta- iminobis. Bioorganic and Medicinal Chemistry Letters 5(15): 1695-1700
Lavergne, J.A.; Albina, J.E.; Saavedra, S.; Del Llano, A.M. 1995: N-methyl mono L-arginine, a nitric oxide inhibitor, reduces apoptosis in cultured PBLs from HIV+ patients. FASEB Journal 9(3): A528
Naoi, M.; Maruyama, W. 1996: N-methyl salsolinol as a candidate neurotoxin to induce Parkinsons disease. Society for Neuroscience Abstracts 22(1-3): 222
Patt, J.T.; Westera, G.; Buck, A.; Fletcher, S.R.; Shubiger, P.A. 1995: N-methyl- and fluoroethylepibatidine Ligands for the neuronal nicotinic receptor. Journal of Labelled Compounds and Radiopharmaceuticals 37: 355-356
Arai, M.; Minatoguchi, S.; Takemura, G.; Uno, Y.; Kariya, T.; Fujiwara, T.; Higashioka, M.; Yoshikuni, Y.; Fujiwara, H. 1997: N-methyl-1-deoxynojirimycin, an alpha-glucosidase inhibitor, reduces markedly infarct size in rabbit hearts. Journal of the American College of Cardiology 29(2 Suppl A): 266A-267A
Cavero, I.; Mondot, S. 1995: N-methyl-2- -tetrahydrothio-pyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for treatment of coronary insufficiency. Official Gazette of the United States Patent and Trademark Office Patents 1175(3): 1804-1805
Mortlock, A.A.; Bath, C.; Butlin, R.J.; Heys, C.; Hunt, S.J.; Reid, A.C.; Sumner, N.F.; Tang, E.K.; Whiting, E.; Wilson, C.; Wright, N.D. 1997: N-methyl-2- phenyl-3-. Bioorganic and Medicinal Chemistry Letters 7(11): 1399-1402
Kassiou, M.; Katsifis, A.; Lambrecht, R.M.; Eu, P.; Hicks, R. 1994: N-methyl-4-iododexetimide A radioiodinated ligand for SPECT studies of myocardial muscarinic receptors. Journal of Labelled Compounds and Radiopharmaceuticals 35: 232-233
Snyder, S.E.; Bormans, G.; Sherman, P.; Kuhl, D.E.; Kilbourn, M.R. 1995: N-methyl-4-piperidinol esters as in vivo substrates for acetylcholinesterase. Journal of Nuclear Medicine 36(5 Suppl): 58P-59P
Ehrlich, P.P.; Didomenico, S.; Lin, C.W.; Bianchi, B.; Stashko, M.; Britton, D.R.; Mikusa, J.; Mahan, L.; Asin, K.; Hodges, L.; Nikkel, A.; Miller, T.; Roberts, E. 1995: N-methyl-5- -phenylhexahydrobenz isoquinoline A novel lead for the development of potent and selective DA D-1 receptor agonists. Abstracts of Papers American Chemical Society 209(1-2): MEDI 72
Rayevsky, K.; Bashkatova, V.; Vitskova, G.; Narkevich, V.; Mikoyan, V.; Vanin, A. 1997: N-methyl-D,L-aspartate dramatically increases nitric oxide content in the rat brain cortex. Journal of Neurochemistry 69(Suppl ): S112
Estienne, M.J.; Hartsock, T.G.; Harter Dennis, J.M.; Barb, C.R. 1993: N-methyl-D,L-aspartate increases concentrations of LH and growth hormone in serum of prepubertal gilts. Journal of Animal Science 71(Suppl 1): 206
Kim, Y.I.; Chandler, S.H. 1993: N-methyl-D,L-aspartate induced voltage oscillations in guinea pig trigeminal motoneurons recorded in vitro. Society for Neuroscience Abstracts 19(1-3): 985
Wu, P.H.; Liu, J.F.; Lanca, A.J.; Arifuzzaman, A.I.; Grupp, L.; Kalant, H. 1995: N-methyl-D-aspartate -induced septal lesion prevents the retention of tolerance to ethanol by desglycinamide-9- -vasopressin. Society for Neuroscience Abstracts 21(1-3): 1339
Beckstead, R.M. 1995: N-methyl-D-aspartate acutely increases proenkephalin mRNA in the rat striatum. Synapse 21(4): 342-347
Spangler, E.; Ingram, D.K.; Kametani, H. 1996: N-methyl-D-aspartate administration in rat hippocampus and striatum increases nitrite and nitrate levels A measure of nitric oxide release. Society for Neuroscience Abstracts 22(1-3): 1532
Sandkuehler, J.; Liu, X.G.; Zimmermann, M. 1995: N-methyl-D-aspartate and neurokinin receptors are critical for the induction of long-term potentiation of C-fiber evoked field potentials in rat spinal dorsal horn. Society for Neuroscience Abstracts 21(1-3): 1641
Neugebauer, V.; Luecke, T.; Schaible, H.G. 1993: N-methyl-D-aspartate and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rats knee joint. Journal of Neurophysiology (Bethesda) 70(4): 1365-1377
Xu, X.; Domino, E.F. 1993: N-methyl-D-aspartate antagonist MK-801 blocks amphetamine induced but not phencyclidine induced behavioral sensitization. Society for Neuroscience Abstracts 19(1-3): 1012
Lam, T.T.; Fu, J.; Li, S.H.; Abler, A.S.; Tso, M.O.M. 1995: N-methyl-D-aspartate induced apoptosis in rat retina. IOVS Investigative Ophthalmology and Visual Science 36(4): S934
Kodama, T.; Honda, Y.; Watanabe, M. 1995: N-methyl-D-aspartate induced cyclic-GMP release as an index of nitric oxide in the laterodorsal tegmental nucleus. Society for Neuroscience Abstracts 21(1-3): 624
Kwong, M.K.; Lam, T.T. 1997: N-methyl-D-aspartate induced delayed cell death in adult rabbit retina. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S101
Zapata, A.; Capdevila, J.L.; Trullas, R. 1997: N-methyl-D-aspartate induces a calcium dependent and region specific increase in extracellular choline levels. Journal of Neurochemistry 69(Suppl ): S76
Shin, C.; Colberg, M.; Sun, X. 1994: N-methyl-D-aspartate induces expression of c-fos mRNA in explant culture of rat hippocampus. Epilepsia 35(Suppl 8): 65
Smyth, C.; Wilkinson, D.; Wilkinson, M. 1996: N-methyl-D-aspartate induces heat shock protein-like immunoreactivity in the hypothalamus of prepubertal female rats. Journal of Physiology (Cambridge) 491P: 179P-180P
Shin, C.; Sun, X.; Colberg, M. 1994: N-methyl-D-aspartate induces the expression of c-fos mRNA in the organotypic culture of rat hippocampus. Society for Neuroscience Abstracts 20(1-2): 613
Landeira Fernandez, J.; Grijalva, C.V. 1993: N-methyl-D-aspartate lesions in the substantia nigra but not in the ventral tegmental area produces gastric erosions in the rat. Society for Neuroscience Abstracts 19(1-3): 959
Pullan, L.M.; Asiedu, S.; Britt, M.; Siddigui, K.; Slusher, B.; Stumpo, R.J. 1994: N-methyl-D-aspartate lesions may create a penumbra of inflammation similar to focal ischemia. Society for Neuroscience Abstracts 20(1-2): 612
Haji, A.; Ohi, Y.; Tsunekawa, S. 2008: N-methyl-D-aspartate mechanisms in depolarization of augmenting expiratory neurons during the expulsive phase of fictive cough in decerebrate cats. Neuropharmacology 54(7): 1120-1127
Lee, K.; Wilson, R.A.; Ross, J.L.; Shin, C. 1996: N-methyl-D-aspartate mediated excitotoxicity induces delayed neuronal death through apoptosis in organotypic culture of rat hippocampus. Epilepsia 37(Suppl 5): 40
Pantazis, N.J.; Dohrman, D.P.; Goodlett, C.R.; West, J.R. 1993: N-methyl-D-aspartate prevents alcohol-induced depletion of cerebellar granule cells in culture. Alcoholism Clinical and Experimental Research 17(2): 453
Allen, R.M.; Tiano, M.J.; Dykstra, L.A. 1998: N-methyl-D-aspartate receptor antagonists potentiate the effects of morphine in a primate model of antinociception. Society for Neuroscience Abstracts 24(1-2): 1868
Mickley, G.A.; Balogh, S.A.; Neimanis, K.; Goulis, P.; Hug, J.; Sauchak, K.; Yamamoto, B.K. 1996: N-methyl-D-aspartate receptor blockade differentially modulates fetal and neonatal conditioned taste aversions Brain ketamine content. Society for Neuroscience Abstracts 22(1-3): 142
Hohimer, A.R.; Bissonnette, J.M.; Knopp, S.J. 1994: N-methyl-D-aspartate receptor blockade increases the depth of fetal breathing movements. FASEB Journal 8(4-5): A909
Hallak, M.; Hotra, J.W.; Anthony, M.J.; Svinarich, D.M. 1998: N-methyl-D-aspartate receptor gene transcription in fetal rat brain Effect of magnesium sulfate. American Journal of Obstetrics and Gynecology 178(1 Part 2): S39
Schwartz, M.; Muler, S.; Belkin, M.; Yoles, E. 1996: N-methyl-D-aspartate receptor is involved in the secondary degeneration induced by optic nerve lesions. IOVS Investigative Ophthalmology and Visual Science 37(3): S493
Mize, R.R.; Butler, G.D. 1995: N-methyl-D-aspartate receptor localization, identified using antibody immunocytochemistry, is primarily postsynaptic in the cat superior colliculus. Society for Neuroscience Abstracts 21(1-3): 1618
Yamamoto, H.; Akama, K.; Kersey, D.; Moskal, J. 1993: N-methyl-D-aspartate receptor mRNA expression in NG108-15 cells undergoing synapse formation. Society for Neuroscience Abstracts 19(1-3): 1357
Nakajima, J.; Kowk, K.; Baimbridge, K.; Kani, K. 1997: N-methyl-D-aspartate receptor mediated calcium accumulation in rat retinal ganglion cells. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S607
Brodsky, M.; Elliott, K.; Warwick, B.; Inturrisi, C.E. 1995: N-methyl-D-aspartate receptor splice variants differ in selected regions of rat CNS. Society for Neuroscience Abstracts 21(1-3): 1836
Shinno, H.; Mikuni, M.; Saitoh, K.; Yamawaki, S.; Takahashi, K. 1993: N-methyl-D-aspartate receptor-like complex is coupled to pertussis toxin-sensitive G-protein and phospholipase C in C6 cell. Society for Neuroscience Abstracts 19(1-3): 1781
Li, J.; Baltas, L.; Huang, K.P.; Huang, F.L. 1998: N-methyl-D-aspartate receptor-mediated oxidation and phosphorylation of neurogranin/RC3 and neuromodulin/GAP43 in rat brain slices. Society for Neuroscience Abstracts 24(1-2): 863
Hochman, S.; Jordan, L.M.; MacDonald, J.F. 1994: N-methyl-D-aspartate receptor-mediated voltage oscillations in neurons surrounding the central canal in slices of rat spinal cord. Journal of Neurophysiology 72(2): 565-577
Binns, K.E.; Salt, T.E. 1995: N-methyl-D-aspartate receptors and cortical influences on visual responses in the superior colliculus of the anaesthetized cat. Journal of Physiology (Cambridge) 485P: 11P-12P
Borkowska, H.D.; Oja, S.S.; Albrecht, I.; Saransaari, P. 1995: N-methyl-D-aspartate receptors and dopamine release in experimental hepatic encephalopathy. Acta Neurobiologiae Experimentalis 55(Suppl ): 51
Hagberg, H.; Andine, P.; Puka, M.; Lazarewicz, J.; Gadamski, R. 1993: N-methyl-D-aspartate receptors and extracellular calcium changes during ischemia in the newborn and adult brain in vivo. Society for Neuroscience Abstracts 19(1-3): 1641
Alesiani, M.; Moroni, F. 1993: N-methyl-D-aspartate receptors are present in the myenteric plexus. Digestive Diseases and Sciences 38(4): 777
Manis, P.B.; Molitor, S.C. 1996: N-methyl-D-aspartate receptors at parallel fiber synapses in the dorsal cochlear nucleus. Journal of Neurophysiology 76(3): 1639-1656
Gillis, R.A.; Henandez, Y.M.; Bingaman, M.; Panico, W.; Silva, A.T.veira Da 1997: N-methyl-D-aspartate receptors at the ventrolateral nucleus tractus solitarius play a role in the termination of inspiration. Society for Neuroscience Abstracts 23(1-2): 725
Williams, J.A.; Colon, R.J.; Weiss, H.R. 1997: N-methyl-D-aspartate receptors control local oxygen consumption and cerebral blood flow in hypoxic newborn pigs. FASEB Journal 11(3): A484
Flynn, K.M.; Alter, E.Y.; Banerjee, S.P.; Schreibman, M.P. 1994: N-methyl-D-aspartate receptors in the brain of Xiphophorus. American Zoologist 34(5): 19A
Phul, R.K.; Smith, M.E. 1996: N-methyl-D-aspartate receptors in the cervical spinal cord in normal and dystrophic C57BL/6J mice in vitro. Journal of Physiology (Cambridge) 491P: 149P-150P
Dennis, T.; Beauchemin, V.; Lavoie, N. 1994: N-methyl-D-aspartate receptors in the rat brain following olfactory bulbectomy Autoradiographic and behavioral studies. Society for Neuroscience Abstracts 20(1-2): 934
Phul, R.K.; Smith, M.E. 1997: N-methyl-D-aspartate receptors in the ventral horn in C57BL/6J normal and dystrophic mice in vitro. Journal of Physiology (Cambridge) 504P: 213P
Young, D.; Nicholson, L.; Dragunow, M. 1994: N-methyl-D-aspartate receptors may be involved in generating electrically-induced status epilepticus. Society for Neuroscience Abstracts 20(1-2): 398
Gozal, D.; Nowak, R.D.; Gozal, Y.M.; Torres, J.E.; Nuckton, T.J.; Graff, G.R. 1996: N-methyl-D-aspartate receptors mediate afferent peripheral chemoreceptor response in the conscious rat. Journal of Investigative Medicine 44(1): 78A
Komuro, H.; Rakic, P. 1992: N-methyl-D-aspartate receptors modulate neuronal migration A laser microscopic study in a cerebellar slice preparation. Society for Neuroscience Abstracts 18(1-2): 1283
Flynn, K.M.; Schreibman, M.P.; Magliulo Cepriano, L.; Banerjee, D.P.; Yablonsky Alter, E. 1995: N-methyl-D-aspartate receptors on gonadotropin releasing hormone neurons. Society for Neuroscience Abstracts 21(1-3): 348
Flynn, K.M.; Schreibman, M.P.; Magliulo Cepriano, L. 1995: N-methyl-D-aspartate receptors on gonadotropin releasing hormone neurons in two species of Xiphophorus. American Zoologist 35(5): 22A
Karadeniz, S.; Tekeli, F.; Bilgic, L.; Guvener, B.; Kucuk, M.; Koyuncuoglu, H. 1998: N-methyl-D-aspartate receptors participate in the retinal damage due to the hypoglycaemia. Diabetologia 41(Suppl 1): A280
Pallotta, M.; Segieth, J.; Whitton, P.S. 1996: N-methyl-D-aspartate receptors regulate 5-HT release in the raphe nuclei and terminal 5-HT release in frontal cortex. British Journal of Pharmacology 119(Proceedings Suppl ): 182P
Fink, K.; Boeing, C.; Schmitz, V.; Goethert, M. 1993: N-methyl-D-aspartate stimulates serotonin and alpha-amino-butyric acid release in the rat and guinea-pig brain cortex. Fundamental and Clinical Pharmacology 7(7): 357
Ono, T.; Ogura, A.; Kudo, Y.; Ikawa, Y. 1993: N-methyl-D-aspartate suppresses apoptosis in cerebellar granule cell and promotes its survival. Neuroscience Research Suppl 1993(18): S135
Said, S.J.; Pakbaz, H.; Berisha, H.I. 1995: N-methyl-D-aspartate- and oxidant-induced lung injury Critical role of poly polymerase. Society for Neuroscience Abstracts 21(1-3): 1028
Youn, D.-H. 2008: N-methyl-D-aspartate-dependent long-term potentiation of excitatory transmission in trigeminal subnucleus oralis. Neuroreport 19(7): 733-738
Kumamoto, E.; Murata, Y. 1993: N-methyl-D-aspartate-induced currents in rat cultured septal neurones. Neuroscience Research Suppl 1993(18): S43
Delaney, S.M.; Geiger, J.D. 1995: N-methyl-D-aspartate-induced increased levels of endogenous adenosine are enhanced by inhibition of adenosine deaminase and adenosine transport in rat striatum. Society for Neuroscience Abstracts 21(1-3): 1374
Damschroder Williams, P.; Paul, S.M. 1993: N-methyl-D-aspartate-induced neuroprotection in cerebellar granule cells Evidence for a developmentally-expressed neuroprotective protein. Society for Neuroscience Abstracts 19(1-3): 1349
Black, M.A.; Tremblay, R.; Mealing, G.A.R.; Ray, R.; Durkin, J.P.; Whitfield, J.F.; Blosser, J.; Morley, P. 1995: N-methyl-D-aspartate-mediated toxicity in cultured rat cortical neurons is antagonized by FPL 15896AR. Society for Neuroscience Abstracts 21(1-3): 1343
Fitzgerald, B.P. 1994: N-methyl-D-aspartic Acid administration to mares Differential gonadotropin release in steroid-treated long-term ovariectomized mares during the breeding season and effects of ovarian status during seasonal anestrus. Biology of Reproduction 50(Suppl 1): 110
Iglesias, G.M.; Moya, A.; Rabunal, R.; Lima, L. 1996: N-methyl-D-aspartic acid and nitric oxide modulate growth hormone secretion in rats. Journal of Physiology (Cambridge) 493P: 41S
Holmgaard, K.; Aalkjaer, C.; Lambert, J.D.C.; Bek, T. 2008: N-methyl-D-aspartic acid causes relaxation of porcine retinal arterioles through an adenosine receptor-dependent mechanism. IOVS Investigative Ophthalmology and Visual Science 49(10): 4590-4594
Sheehan, T.; Paul, M.; Cirrito, J.; Numan, M. 1998: N-methyl-D-aspartic acid lesions of the medial amygdala facilitate maternal behavior in female rats hysterectomized and ovariectomized on day 12 of pregnancy. Society for Neuroscience Abstracts 24(1-2): 953